Education Information
2006 - 2010
2006 - 2010Post Doctorate of Medicine
Erciyes University, Tıp Fakültesi, Dahili Tıp Bil., Turkey
2000 - 2005
2000 - 2005Expertise In Medicine
Erciyes University, Tıp Fakültesi, Dahili Tıp Bil., Turkey
1993 - 2000
1993 - 2000Undergraduate
Erciyes University, Tıp Fakültesi, Tıp Pr., Turkey
Foreign Languages
C1 Advanced
C1 AdvancedEnglish
Certificates, Courses and Trainings
2012
2012TERAPÖTİK AFEREZ SERTİFİKASI
Health&Medicine
MINISTRY OF HEALTH
Research Areas
Medicine
Health Sciences
Fundamental Medical Sciences
Microbiology and Clinical Microbiology
Immunology
Internal Diseases
Hematology
Oncology
Life Sciences
Molecular Biology and Genetics
Cytogenetic
Natural Sciences
Academic Titles / Tasks
2021 - Continues
2021 - ContinuesProfessor
Istanbul Medipol University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2018 - 2021
2018 - 2021Professor
Erciyes University, Tıp Fakültesi, Dahili Tıp Bil.
2017 - 2020
2017 - 2020Professor
KING HAMAD UNIVERSITY HOSPITAL, MEDICAL FACULTY, HEMATOLOGY ONCOLOGY DEPARTMENT
2012 - 2018
2012 - 2018Associate Professor
Erciyes University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2009 - 2012
2009 - 2012Assistant Professor
Erciyes University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2011 - 2011
2011 - 2011Assistant Professor
Duke University, MEDICAL FACULTY, Hematology Department
Managerial Experience
2021 - Continues
2021 - ContinuesHead of Department
Istanbul Medipol University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
2013 - 2023
2013 - 2023Aferez Komisyonu Üyeliği
SAĞLIK BAKANLIĞI
2014 - 2021
2014 - 2021Aferez Ünite Sorumlusu
Erciyes University, Tıp Fakültesi, Dahili Tıp Bil.
2017 - 2020
2017 - 2020Head of Hematology Department
King Hamad Hematology Oncology Hospital
2017 - 2018
2017 - 2018Head of Department
Erciyes University, Tıp Fakültesi, Dahili Tıp Bil.
Courses
Undergraduate
Undergraduate
İÇ HASTALIKLARI
Akut Lösemi
hematoloji
İç Hastalıkları - Kemik İliği yetersizlikleri
İÇ HASTALIKLARI - AKUT LÖSEMİLER
İç Hastalıkları- Kronik myeloproliferatif hastalıklar
Primer Hemostaz Bozuklukları
Semptomdan Klinik Tanıya Vakalarla Hematoloji
HEMATOLOJİ STAJYER HASTA BAŞI EĞİTİM PROGRAMI
Kanamalı Hastaya Yaklaşım I (Koagülasyon Sistemi Bozuklukları)
Aferez
Fizik Muayene
KOAGÜLASYON SİSTEMİ, PIHTILAŞMA FAKTÖRLERİ
KOAGÜLASYON MEKANİZMASI VE KOAGÜLASYON TESTLERİ
KRONİK MYELOPROLİFERATİF HASTALIKLAR
KRONİK LÖSEMİLER
Trombosit Hastalıkları
Kan grupları ve kan transfüzyon reaksiyonları
APLASTİK VE HİPOPLASTİK ANEMİLER
Kan Grupları, Kan Transfüzyonu veReaksiyonları, Cross-Match
Kliniğin Tanıtımı
Aferez ve Prensipleri
Hematopoetik Sistem
Supervised Theses
2022
2022Postgraduate
Expression of CD38 by neoplastic cells in hematological malignancies
Kaynar L. (Advisor)
M.Isa(Student)
2020
2020Expertise In Medicine
Allojenik kök hücre nakli yapılan hastalarda nakil sonrası c-reaktif protein düzeyinin artışının değerlendirilmesi
Leylagül K. (Advisor)
M.İKBAL(Student)
2020
2020Postgraduate
Kronik miyeloid lösemi (KML) tanı ve takibinde mikro-RNA'ların kullanılmasının araştırılması
Leylagül K. (Advisor)
H.ALTIN(Student)
2018
2018Expertise In Medicine
Otolog kök hücre nakli hastalarında sitomegalovirüs pozitifliği, tarama ve tedavi yaklaşımı
Leylagül K. (Advisor)
M.ILGAZ(Student)
2017
2017Expertise In Medicine
Allojenik kök hücre nakli yapılan lösemi ve myelodisplastik sendrom hastalarında nakil sonrası gelişen nükslerin değerlendirilmesi
Leylagül K. (Advisor)
H.BETÜL(Student)
2016
2016Expertise In Medicine
Kemoterapi almış hematolojik maligniteli hastalarda CMV PCR takibinin önemi
Leylagül K. (Advisor)
T.DÜNDAR(Student)
2015
2015Expertise In Medicine
Allojenik kök hücre nakli yapılan hastalarda nakil sonrası görülen karaciğer fonksiyon testi bozukluklarının değerlendirilmesi
Leylagül K. (Advisor)
M.KIZILTEPE(Student)
2011
2011Expertise In Medicine
Otolog hematopoetik kök hücre nakli yapılan lenfoma hastalarında sağkalım üzerine etkisi olan faktörlerin belirlenmesi
Leylagül K. (Advisor)
T.SEZGİN(Student)
2010
2010Expertise In Medicine
Allojenik hematopoetik kök hücre nakli yapılan hastalarda sağkalım üzerine etkisi olan faktörlerin belirlenmesi
Leylagül K. (Advisor)
C.ŞAHİN(Student)
Published journal articles indexed by SCI, SSCI, and AHCI
2025
2025When high dose methotrexate stops working, a successful bridge to transplant with TEDDI-R in a case of secondary CNS lymphoma
Kaya S., Melek E., Mutlu Y., Beköz H., Maral S., Kaynar L., et al.
ANNALS OF HEMATOLOGY
, 2025 (SCI-Expanded)
2025
2025A complete response with daratumumab, venetoclax, azacitidine and dexamethasone in a heavily pre-treated, chemo-refractory early T-precursor acute lymphoblastic leukemia/lymphoma patient
Yiğit Kaya S., Vatani M., Akil R., Cakir T., Maral S., Kaynar L., et al.
ANNALS OF HEMATOLOGY
, 2025 (SCI-Expanded)
2024
2024Evaluation of HOTAIR, HOXD8, HOXD9, HOXD11 gene expression levels in Turkish patients with acute and chronic myeloid leukemia: A single center experience
Saraymen E., Erdem Y., Akalın H., Taşçıoğlu N., Saraymen B., Çelik S., et al.
CELLULAR AND MOLECULAR BIOLOGY
, vol.70, no.11, pp.39-45, 2024 (SCI-Expanded)
2024
2024Atypical presentation of PJP: hypercalcemia and kidney injury in an allogeneic stem cell transplant recipient
ÖZALP Y. C., Shehabie H., Tekin M. G., Kaya S. Y., BEKÖZ H. S., MARAL S., et al.
BMC INFECTIOUS DISEASES
, vol.24, no.1, pp.1201, 2024 (SCI-Expanded)
2024
2024Original vs. Generic Plerixafor for the Mobilization of Stem Cells in Multiple Myeloma Patients
Yiğit Kaya S., MUTLU Y. G., YÜCEL O. K., Nizam Özen İ., Ataş Ü., MELEK E., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, 2024 (SCI-Expanded)
2024
2024Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study
Metan G., Çiftçioğlu A., Saba R., Kılıç A. U., Özdemir K., Çağ Y., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, 2024 (SCI-Expanded)
2024
2024Eltrombopag treatment in thrombocytopenia following hematopoietic stem cell transplantation: A multicenter real-world experience
Kilic Gunes E., Yigit Kaya S., Yaman F., Yeniay M. K., Vural K., Comert M., et al.
LEUKEMIA RESEARCH
, vol.140, 2024 (SCI-Expanded)
2024
2024Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience
Yiğit Kaya S., MUTLU Y. G., MALKAN Ü. Y., MEHTAP Ö., Keklik Karadağ F., Korkmaz G., et al.
LEUKEMIA RESEARCH
, vol.140, 2024 (SCI-Expanded)
2024
2024Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia
Mulder J. W. C. M., Tromp T. R., Al-Khnifsawi M., Blom D. J., Chlebus K., Cuchel M., et al.
JAMA CARDIOLOGY
, vol.9, no.4, pp.313-322, 2024 (SCI-Expanded)
2024
2024Protective role of olive oil extract of propolis on short and long-term administration of tamoxifen in rats
SİLİCİ S., KAYNAR L., OKAN OFLAMAZ A., DOĞANYİĞİT Z.
ENVIRONMENTAL TOXICOLOGY
, vol.39, no.4, pp.2102-2122, 2024 (SCI-Expanded)
2024
2024The effect of danger-associated molecular patterns on survival in acute graft versus host disease
Çelik S., KAYNAR L., Güven Z. T., Atasever Duran K., KONTAŞ O., KEKLİK M., et al.
BONE MARROW TRANSPLANTATION
, vol.59, no.2, pp.189-195, 2024 (SCI-Expanded)
2024
2024A Case of Rapidly Progressing Tumoral-Stage Mycosis Fungoides
Keklik M., Çınar S. L., Şimşek R., Kaynar L.
TURKISH JOURNAL OF HEMATOLOGY
, vol.41, no.4, pp.291-292, 2024 (SCI-Expanded)
2023
2023The impact of diabetes mellitus on hematopoietic stem cell mobilization, a-single center cohort study
ÇELİK S., KAYNAR L., Güven Z. T., Begendi N. K., Demir F., KEKLİK M., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.62, no.6, 2023 (SCI-Expanded)
2023
2023Plerixafor in autologous stem cell transplantation: Does it affect engraftment kinetics?
Serin I., SEVİNDİK Ö. G., Balik Aydin B., MELEK E., MUTLU Y. G., BİLGEN H., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.62, no.6, 2023 (SCI-Expanded)
2023
2023Relapsed refractory multiple myeloma with CNS involvement successfully treated with Elranatamab: first reported case
Mutlu Y. G., Yıgıt Kaya S., Maral S., Melek E., Başlar Z., Kaynar L., et al.
FRONTIERS IN IMMUNOLOGY
, vol.14, 2023 (SCI-Expanded)
2023
2023Safety and efficacy of mesenchymal stromal cell therapy for multi-drug-resistant acute and late-acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation
Keklik M., Deveci B., Celik S., Deniz K., Gönen Z. B., Zararsız G., et al.
Annals of Hematology
, vol.102, no.6, pp.1537-1547, 2023 (SCI-Expanded)
2023
2023Prognostic Factors and Intensive Care Outcome in Post-Transplant Phase of Hematopoietic Stem Cell Transplantation: Intensive Care Outcome in Hematopoietic Stem Cell Transplantation
MUTLU Y. G., Aydin B. B., ERDOĞAN C., KIZILASLAN D., BEKÖZ H. S., Gemici A., et al.
Indian Journal of Hematology and Blood Transfusion
, vol.39, no.2, pp.167-172, 2023 (SCI-Expanded)
2023
2023Inherited transmission of the CSF3R T618I mutation: a familial report
Serin I., Cinli T. A., Tunc S., KAYNAR L., SEVİNDİK Ö. G., Yokus O.
Annals of Hematology
, vol.102, no.2, pp.477-479, 2023 (SCI-Expanded)
2023
2023Antibody Response against Vaccine Antigens in Children after TCRαβ-Depleted Haploidentical Stem Cell Transplantation: Is It Similar to That in Recipients with Fully Matched Donors?
Kondolot M., Yılmaz E., Erdog Sahin N., Özcan A., Kaynar L., Ünal E., et al.
TRANSPLANTATION AND CELLULAR THERAPY
, vol.29, no.2, 2023 (SCI-Expanded)
2023
2023Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey
Dal M. S., Ulu B. U., UZAY A., Akay O. M., Beşışık S., Yenerel M. N., et al.
Annals of Hematology
, vol.102, no.1, pp.133-140, 2023 (SCI-Expanded)
2022
2022CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study
Demirci U., Kırkızlar H. O., ÜMİT E. G., Gürsoy V., Pınar İ. E., ÖZKALEMKAŞ F., et al.
Journal of Hematopathology
, vol.15, no.4, pp.203-213, 2022 (SCI-Expanded)
2022
2022Evaluation of COVID-19 fear and quality of life in patients with haematopoietic stem cell transplantation during the COVID-19 pandemic
Çelik S., Güven Z. T., İpekten F., Keklik M., Ünal A., Kaynar L.
EUROPEAN JOURNAL OF CANCER CARE
, vol.31, no.5, 2022 (SCI-Expanded)
2022
2022The Effect of Mesenchymal Stromal Cells on the Mortality of Patients with Sepsis and Septic Shock: A Promising Therapy
Alp E., Gonen Z. B., Gundogan K., Esmaoglu A., Kaynar L., Cetin A., et al.
EMERGENCY MEDICINE INTERNATIONAL
, vol.2022, pp.9222379, 2022 (SCI-Expanded)
2022
2022Secondary Hypogammaglobulinemia in Patients with Chronic Lymphocytic Leukemia Receiving Ibrutinib Therapy
Çelik S., KAYNAR L., Güven Z. T., Baydar M., KEKLİK M., Çetin M., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.38, no.2, pp.282-289, 2022 (SCI-Expanded)
2022
2022Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
Hovingh G. K., Ray K. K., Soran H., Freiberger T., Bertolini S., Harada-Shiba M., et al.
LANCET
, vol.399, no.10326, pp.719-728, 2022 (SCI-Expanded)
2022
2022Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study
Akpinar S., Tekgunduz E., Esen R., Yilmaz M., Karakus V., Vural F., et al.
Transfusion and Apheresis Science
, vol.61, no.1, 2022 (SCI-Expanded)
2022
2022Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA)
Kaynar L., Tekgunduz E., Kozanoglu I., Ozkan H. A., Aksu S., Özkalemkaş F., et al.
Transfusion and Apheresis Science
, vol.61, no.1, 2022 (SCI-Expanded)
2022
2022Eltrombopag for Treatment of Thrombocytopenia Following Hematopoietic Stem Cell Transplantation
Güven Z. T., Çelik S., Eser B., Çetin M., ÜNAL A., KAYNAR L.
TURKISH JOURNAL OF HEMATOLOGY
, vol.39, no.2, pp.103-108, 2022 (SCI-Expanded)
2022
2022Impact of K-ras Mutation and C-myc Overexpression on the Prognosis of Diffuse Large B-Cell Lymphomas
Ketenci Ertas S., Unal A., Akalin H., Baran M., Canoz O., Kontas O., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.32, no.1, pp.16-22, 2022 (SCI-Expanded)
2022
2022Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies COVID-19 Geçiren Türk Hematolojik Malignite Hastalarının Klinik Özellikleri ve Sonuçları
Bozdağ S. C., Seval G. C., Hindilerden İ. Y., Hindilerden F., ANDIÇ N., BAYDAR M., et al.
Turkish Journal of Hematology
, vol.39, no.1, pp.43-54, 2022 (SCI-Expanded)
2021
2021Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study
Akay O. M., Ozbalak M., Pehlivan M., Yildiz B., UZAY A., Yigenoglu T. N., et al.
HEMATOLOGICAL ONCOLOGY
, vol.39, no.4, pp.498-505, 2021 (SCI-Expanded)
2021
2021Efficacy of therapeutic plasma exchange in patients with Crimean-Congo hemorrhagic fever
Beştepe Dursun Z., Korkmaz S., TÜRE YÜCE Z., KAYNAR L., Dursun A., Çelik İ.
JOURNAL OF CLINICAL APHERESIS
, vol.36, no.3, pp.390-397, 2021 (SCI-Expanded)
2021
2021Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience
Yılmaz F., Soyer N., Seval G. C., Bozdağ S. C., TOPÇUOĞLU P., ÜNAL A., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.38, no.3, pp.195-203, 2021 (SCI-Expanded)
2021
2021The use of high-flow nasal oxygen vs. standard oxygen therapy in hematological malignancy patients with acute respiratory failure in hematology wards.
Apltekinoğlu Mendil N., TEMEL Ş., YÜKSEL R. C., GÜNDOĞAN K., Eser B., KAYNAR L., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.51, no.4, pp.1756-1763, 2021 (SCI-Expanded)
2021
2021Prospective registry of adult patients receiving therapeutic plasma exchange with a presumptive diagnosis of thrombotic microangiopathy (TMA): The Turkish hematology research and education group (ThREG)-TMA02 study
Akpınar S., Tekgunduz E., ERKURT M. A., Esen R., YILMAZ M. B., Karakus V., et al.
Transfusion and Apheresis Science
, 2021 (SCI-Expanded)
2020
2020Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience
Bekoz U., Ozbalak M., Karadurmus N., Paydaş S., Turker A., Toptaş T., et al.
ANNALS OF HEMATOLOGY
, vol.99, no.11, pp.2565-2576, 2020 (SCI-Expanded)
2020
2020A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity
Yeral M., Aytan P., Gungor B., Boga C., ÜNAL A., Koc Y., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.20, no.10, pp.652-660, 2020 (SCI-Expanded)
2020
2020Low-dose cyclophosphamide and granulocyte colony-stimulating factor are sufficient for peripheral blood stem cell mobilization in patients with multiple myeloma
KEKLİK M., Karakus E., KAYNAR L., Akyol G., Guven Z. T., Celik S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.59, no.5, 2020 (SCI-Expanded)
2020
2020Investigation of Ganciclovir Resistance in Cytomegalovirus Strains Obtained from Immunocompromised Patients
Coşkun A., GÖKAHMETOĞLU S., Özmen P., Çevik Ş., KARAKÜKCÜ M., KAYNAR L., et al.
MIKROBIYOLOJI BULTENI
, vol.54, no.4, pp.619-628, 2020 (SCI-Expanded)
2020
2020Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma
Beksac M., Aydin Y., Goker H., Turgut M., Besisik S. K., Cagirgan S., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.20, no.8, 2020 (SCI-Expanded)
2020
2020Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party
Penack O., Peczynski C., van der Werf S., Finke J., Ganser A., Schoemans H., et al.
HAEMATOLOGICA
, vol.105, no.7, pp.1977-1983, 2020 (SCI-Expanded)
2020
2020Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)
Kuman Tunçel Ö., Kayıkçıoğlu M., Pırıldar Ş., YILMAZ M. B., KAYNAR L., Aktan M., et al.
JOURNAL OF CLINICAL LIPIDOLOGY
, vol.14, no.3, pp.361, 2020 (SCI-Expanded)
2020
2020Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party
Penack O., Peczynski C., van der Werf S., Finke J., Ganser A., Schoemans H., et al.
FRONTIERS IN IMMUNOLOGY
, vol.11, pp.586, 2020 (SCI-Expanded)
2020
2020Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience
Özbalak M., SALİHOĞLU A., Soysal T., Karadoğan İ., PAYDAŞ S., Özdemir E., et al.
ANNALS OF HEMATOLOGY
, vol.99, no.2, pp.301-307, 2020 (SCI-Expanded)
2019
2019Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)
Kayikcioglu M., Kuman-Tunçel O., Pirildar S., YILMAZ M. B., KAYNAR L., Aktan M., et al.
JOURNAL OF CLINICAL LIPIDOLOGY
, vol.13, no.3, pp.455-467, 2019 (SCI-Expanded)
2019
2019Infection control bundles in intensive care: an international cross-sectional survey in low- and middle-income countries
Alp E., Cookson B., Erdem H., Rello J., Akhvlediani T., Akkoyunlu Y., et al.
JOURNAL OF HOSPITAL INFECTION
, vol.101, no.3, pp.248-256, 2019 (SCI-Expanded)
2019
2019Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
Scully M., Cataland S., Peyvandi F., Coppo P., Knöl P., Kremer Hovinga J., et al.
NEW ENGLAND JOURNAL OF MEDICINE
, vol.380, no.4, pp.335-346, 2019 (SCI-Expanded)
2019
2019Acute lymphoblastic leukemia in routine practice: A Turkish multicenter study Rutin uygulamada akut lenfoblastik lösemi: Türkiye’den çok merkezli bir çalışma
Çiftçiler R., SEVİNDİK Ö. G., Tekgündüz A. İ. E., ERKURT M. A., Vural F., Turgut B., et al.
Turkish Journal of Hematology
, vol.36, no.3, pp.169-177, 2019 (SCI-Expanded)
2018
2018Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up
Saydam G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A. S., ALİ R., GÜVENÇ B., et al.
HEMATOLOGY
, vol.23, no.10, pp.771-777, 2018 (SCI-Expanded)
2018
2018Response to the Letter to the Editor: Critically ill Haematological Cancer Patients: How far the Severity Index Score can determine the outcome and duration of Aggressive Support?
Alp E., Tok T., KAYNAR L., Cevahir F., Akbudak İ. H., GÜNDOĞAN K., et al.
AUSTRALIAN CRITICAL CARE
, vol.31, no.6, pp.339, 2018 (SCI-Expanded)
2018
2018Outcomes for haematological cancer patients admitted to an intensive care unit in a university hospital
Alp E., Tok T., KAYNAR L., Cevahir F., Akbudak İ. H., GÜNDOĞAN K., et al.
AUSTRALIAN CRITICAL CARE
, vol.31, no.6, pp.363-368, 2018 (SCI-Expanded)
2018
2018What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?
Kayikcioglu M., Tokgozoglu L., Dogan V., Ceyhan C., Tuncez A., Kutlu M., et al.
ATHEROSCLEROSIS
, vol.277, pp.341-346, 2018 (SCI-Expanded)
2018
2018Endothelial Nitric Oxide Synthase Gene Variants and Susceptibility to Chronic Myeloid Leukemia (Ph plus )
Pehlivan M., Pehlivan S., Kaynar L., Sever T., Yilmaz M., Eser B., et al.
INTERNATIONAL JOURNAL OF HUMAN GENETICS
, vol.18, no.3, pp.247-252, 2018 (SCI-Expanded)
2018
2018A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)
Kayikcioglu M., Tokgozoglu L., YILMAZ M. B., KAYNAR L., Aktan M., Durmuş R. B., et al.
ATHEROSCLEROSIS
, vol.270, pp.42-48, 2018 (SCI-Expanded)
2018
2018A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study
Tekgündüz E., Yılmaz M., ERKURT M. A., Kiki I., Kaya A. H., KAYNAR L., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.57, no.1, pp.27-30, 2018 (SCI-Expanded)
2018
2018High Metabolic Tumor Volume and Total Lesion Glycolysis Derived from Baseline <SUP>18</SUP>F-FDG PET/CT may Predict the Metabolic Abnormalities in Newly Diagnosed Cancer Patients
ÇETİN A., ABDÜLREZZAK Ü., YILMAZ S., ZARARSIZ G., AKKURT S., Ucar M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.28, no.2, pp.69-78, 2018 (SCI-Expanded)
2017
2017Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG)
Tekgündüz E., DEMİRKAN F., Vural F., GÖKER H., Özdoğu H., Kiki İ., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.56, no.6, pp.804-808, 2017 (SCI-Expanded)
2017
2017Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma
Dogu M. H., Çagirgan S., Ocakci S., Kaya A. H., Ilkkilic K., Sanli N. M., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.56, no.6, pp.814-818, 2017 (SCI-Expanded)
2017
2017Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA)
Tekgündüz E., Arat M., GÖKER H., Özdoğu H., KAYNAR L., Çağırgan S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.56, no.6, pp.845-849, 2017 (SCI-Expanded)
2017
2017A case of multiple myeloma with navicular bone involvement
Yildizhan E., KAYNAR L., Tiren N., CANÖZ Ö., Eser B.
SCOTTISH MEDICAL JOURNAL
, vol.62, no.4, pp.152-155, 2017 (SCI-Expanded)
2017
2017Nivolumab for relapsed or refractory Hodgkin lymphoma: Real-life experience
Beköz H., Karadurmuş N., Paydaş S., Türker A., Toptaş T., Firatli Tuğlular T., et al.
Annals of Oncology
, vol.28, no.10, pp.2496-2502, 2017 (SCI-Expanded)
2017
2017Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia
Demiraslan H., Atalay M. A., Eren E., Demir K., Kaynar L., Koç A., et al.
MEDICAL MYCOLOGY
, vol.55, no.5, pp.535-540, 2017 (SCI-Expanded)
2017
2017Additional infusions of mesenchymal stem cells improve response rate in multidrug-resistant GvHD patients
ÇETİN M., Akyol G., GÖNEN Z. B., KEKLİK M., ZARARSIZ G., ÜNAL A., et al.
BONE MARROW TRANSPLANTATION
, vol.52, no.5, pp.783-785, 2017 (SCI-Expanded)
2017
2017Performance of Galactomannan Antigen, Beta-D-Glucan, and <i>Aspergillus</i>-Lateral-Flow Device for the Diagnosis of Invasive Aspergillosis
Metan G., KEKLİK M., DİNÇ G., Pala Ç., Yıldırım A., SARAYMEN B., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.33, no.1, pp.87-92, 2017 (SCI-Expanded)
2017
2017Fungemia and Septic Arthritis Caused by <i>Saprochaete capitata</i> in a Patient with Fanconi Aplastic Anemia: A Case Report
Parkan Ö. M., ATALAY M. A., KOÇ A. N., Pala Ç., Aydemir G., KAYNAR L.
MIKROBIYOLOJI BULTENI
, vol.51, no.1, pp.87-93, 2017 (SCI-Expanded)
2017
2017Unicentric Castleman’s disease associated with end stage renal disease caused by amyloidosis
EROĞLU E., KOÇYİĞİT İ., ÜNAL A., SİPAHİOĞLU M. H., AKGÜN H., KAYNAR L., et al.
WORLD JOURNAL OF CLINICAL CASES
, vol.5, no.3, pp.119, 2017 (SCI-Expanded)
2017
2017TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients
KAYNAR L., Demir K., Turak E. E., Öztürk Ç. P., ZARARSIZ G., GÖNEN Z. B., et al.
HEMATOLOGY
, vol.22, no.3, pp.136-144, 2017 (SCI-Expanded)
2016
2016Increased Bone Marrow Iron Scores Are Strongly Correlated With Elevated Serum Ferritin Levels and Poorer Survival in Patients With Iron Overload That Underwent Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience
Sivgin S., Nazlim S., ZARARSIZ G., Baspinar O., KAYNAR L., DENİZ K., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.16, no.10, pp.582-587, 2016 (SCI-Expanded)
2016
2016Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase
Saydam G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A. S., ALİ R., GÜVENÇ B., et al.
EXPERT OPINION ON PHARMACOTHERAPY
, vol.17, no.14, pp.1851-1858, 2016 (SCI-Expanded)
2016
2016Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
Sivgin S., Baldane S., DENİZ K., ZARARSIZ G., KAYNAR L., Cetin M., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.16, 2016 (SCI-Expanded)
2016
2016The Prognostic Significance of Elevated Serum Ferritin Levels Prior to Transplantation in Patients With Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation (autoHSCT): Role of Iron Overload
Sivgin S., Karamustafaoglu M. F., Yildizhan E., ZARARSIZ G., KAYNAR L., Eser B., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.16, 2016 (SCI-Expanded)
2016
2016Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34<SUP>+</SUP> peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors
Sivgin S., Karakus E., KEKLİK M., ZARARSIZ G., Solmaz M., KAYNAR L., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.54, no.3, pp.410-415, 2016 (SCI-Expanded)
2016
2016Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience
Tekgündüz E., GÖKER H., KAYNAR L., Sari I., Pala Ç., Doǧu M. H., et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
, vol.16, no.5, pp.269-274, 2016 (SCI-Expanded)
2016
2016Long-term efficacy of lipoprotein apheresis in the management of familial hypercholesterolaemia: Application of two different apheresis techniques in childhood
Gokay S., Kendirci M., KAYNAR L., Solmaz M., ÇETİN A., KARDAŞ F., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.54, no.2, pp.282-288, 2016 (SCI-Expanded)
2016
2016Retrospective analysis of adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: A multicenter experience of daily practice
Tekgündüz E., KAYNAR L., GÖKER H., Kaya A. H., Turak E. E., Eliaçik E., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.54, no.1, pp.41-47, 2016 (SCI-Expanded)
2016
2016Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study
Chanan-Khan A., Cramer P., Demirkan F., Fraser G., Silva R. S., Grosicki S., et al.
LANCET ONCOLOGY
, vol.17, no.2, pp.200-211, 2016 (SCI-Expanded)
2016
2016The high prevalence of <i>Encephalitozoon intestinalis</i> in patients receiving chemotherapy and children with growth retardation and the validity of real-time PCR in its diagnosis
ÇETİNKAYA Ü., Yazar S., Kuk S., Sivcan E., KAYNAR L., ARSLAN D., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.46, no.4, pp.1050-1058, 2016 (SCI-Expanded)
2016
2016Response to imatinib in patient with corticosteroid-unresponsive idiopatic hypereosinophilic syndrome
YILMAZ İ., KAYNAR L., TUTAR N., PALA Ç., CANÖZ Ö., Buyukoglan H., et al.
REVISTA PORTUGUESA DE PNEUMOLOGIA
, vol.22, no.1, pp.59-60, 2016 (SCI-Expanded)
2016
2016Factors affecting survival in acute leukemia with donor lymphocyte infusion in the first relapse after allogeneic stem cell transplantation
Kurnaz F., Sahin C., Kaynar L., Pala C., Sivgin S., Altuntas F., et al.
Journal of B.U.ON.
, vol.21, no.1, pp.227-234, 2016 (SCI-Expanded)
2016
2016The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study
Tombak A., Uçar M. A., Akdeniz A., Tiftik E. N., Şahin D. G., Akay O. M., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.33, no.4, pp.273-280, 2016 (SCI-Expanded)
2016
2016Molecular epidemiology and antifungal susceptibility of <i>Saprochaete</i> <i>capitata</i> (<i>Blastoschizomyces</i> <i>capitatus</i>) isolates causing nosocomial infection in Kayseri/Turkey
KOÇ A., ATALAY M. A., Timur D., Demir G., KAYNAR L.
INFECTIOUS DISEASES
, vol.48, no.8, pp.596-603, 2016 (SCI-Expanded)
2016
2016Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders
AKSU S., Ayyildiz O., Etgul S., GÖKER H., Gunes G., HAZNEDAROĞLU İ. C., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.26, no.1, pp.12-19, 2016 (SCI-Expanded)
2015
2015Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
Burger J. A., Tedeschi A., Barr P. M., Robak T., Owen C., Ghia P., et al.
NEW ENGLAND JOURNAL OF MEDICINE
, vol.373, no.25, pp.2425-2437, 2015 (SCI-Expanded)
2015
2015Tigecycline for the treatment of <i>Clostridium difficile</i> infection refractory to metronidazole in haematopoietic stem cell transplant recipients
Metan G., TÜRE YÜCE Z., KAYNAR L., Berk E., GÜRSOY Ş., Alp E., et al.
JOURNAL OF CHEMOTHERAPY
, vol.27, no.6, pp.354-357, 2015 (SCI-Expanded)
2015
2015Investigation of the Presence of Encephalitozoon intestinalis and Enterocytozoon bieneusi in Bone Marrow Transplant Patients by IFA-MAbs Method Kemik İliği Transplant Hastalarında Encephalitozoon intestinalis ve Enterocytozoon bieneusi Varlığının IFA-MAbs Yöntemiyle Araştırılması
Çetinkaya Ü., Hamamcı B., Kaynar L., Kuk S., Şahin İ., Yazar S.
Mikrobiyoloji Bulteni
, vol.49, no.3, pp.432-438, 2015 (SCI-Expanded)
2015
2015Hepatic iron overload (HIO) is strongly correlated with serum ferritin levels and inferior survival in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT)
Sivgin S., Baldane S., Deniz K., Zararsiz G., Kaynar L., Cetin M., et al.
CLINICAL LYMPHOMA, MYELOMA AND LEUKEMIA , vol.15, pp.3-4, 2015 (SCI-Expanded)
2015
2015A Single Center Experience for Antifungal Prophylaxis in Patients with Acute Myelogenous Leukemia
Metan G., TÜRE YÜCE Z., Pala Ç., KAYNAR L., Yıldırım A., Elmalı F., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.31, no.3, pp.339-345, 2015 (SCI-Expanded)
2015
2015<i>Saprochaete capitata</i> as an emerging fungus among patients with haematological malignencies
Ulu-Kilic A., ATALAY M. A., Metan G., Cevahir F., Koç N., Eser B., et al.
MYCOSES
, vol.58, no.8, pp.491-497, 2015 (SCI-Expanded)
2015
2015Peripheral blood stem cell mobilization failure
Kurnaz F., KAYNAR L.
TRANSFUSION AND APHERESIS SCIENCE
, vol.53, no.1, pp.3-7, 2015 (SCI-Expanded)
2015
2015Investigation of Ganciclovir Resistance in CMV UL54 and UL97 Gene Regions in Immunocompromised Patients Receiving Gancyclovir Treatment Gansiklovir Tedavisi Alan İmmün Yetmezlikli Hastalarda, CMV UL54 ve UL97 Gen Bölgelerinde Gansiklovir Direncinin Araştırılması
Delice S., Gökahmetoğlu S., Kaynar L., Karakükcü M.
Mikrobiyoloji Bulteni
, vol.49, no.3, pp.393-402, 2015 (SCI-Expanded)
2015
2015Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators
KEKLİK M., Eser B., KAYNAR L., Sivgin S., Keklik E., Solmaz M., et al.
JOURNAL OF CLINICAL APHERESIS
, vol.30, no.3, pp.171-175, 2015 (SCI-Expanded)
2015
2015Diffuse Large B-Cell Lymphoma in adults aged 65 years and older: A retrospective multicenter analysis of clinical characteristics and therapeutic outcomes
Doğu M. H., Keklik M., Terzi H., Korkmaz S., Erkurt M. A., Caglıyan G. A., et al.
Clinical Lymphoma Myeloma and Leukemia , vol.15, pp.218, 2015 (SCI-Expanded)
2015
2015Does the Level of <i>WT1</i> Expression Predict the Outcome in Philadelphia-Negative Myeloproliferative Neoplasms?
Tasdemir S., ŞENER E. F., AKALIN H., KEKLİK M., KAYNAR L., ÖZKUL Y.
GENETIC TESTING AND MOLECULAR BIOMARKERS
, vol.19, no.4, pp.222-224, 2015 (SCI-Expanded)
2015
2015Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
SALİHOĞLU A., ELVERDİ T., Karadogan I., PAYDAŞ S., ÖZDEMİR E., Erdem G., et al.
ANNALS OF HEMATOLOGY
, vol.94, no.3, pp.415-420, 2015 (SCI-Expanded)
2015
2015Contribution of Involved-field Radiotherapy to Survival in Patients With Relapsed or Refractory Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation
Eroglu C., KAYNAR L., ORHAN O., KEKLİK M., Sahin C., Yildiz O. G., et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, vol.38, no.1, pp.68-73, 2015 (SCI-Expanded)
2015
2015Prevalence of <i>Encephalitozoon intestinalis</i> and <i>Enterocytozoon bieneusi</i> in Cancer Patients Under Chemotherapy
Hamamci B., ÇETİNKAYA Ü., Berk V., KAYNAR L., Kuk S., Yazar S.
MIKROBIYOLOJI BULTENI
, vol.49, no.1, pp.105-113, 2015 (SCI-Expanded)
2014
2014PP-015 IMPACT ON PROGNOSIS OF K-RAS MUTATION AND C-MYC OVEREXPRESSION AT DIFFUSE LARGE B-CELL LYMPHOMAS
Ertas S. K., Inal A., Keklik M., Ozkul Y., Akalin H., Canoz I., et al.
LEUKEMIA RESEARCH , vol.38, pp.32, 2014 (SCI-Expanded)
2014
2014PP-022 EFFICIENCY OF PLERIXAFOR FOR AUTOLOGOUS STEM CELL MOBILIZATION: SINGLE-CENTER EXPERIENCE
Kaynar L., Akyol G., Ünal A., Pala Ç., Ermiş Turak E., Şıvgın S., et al.
LEUKEMIA RESEARCH , vol.38, pp.34, 2014 (SCI-Expanded)
2014
2014Comparison of double dose plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC and Trima Accel cell separators
KEKLİK M., Eser B., KAYNAR L., Solmaz M., ÖZTÜRK A., Yay M., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.51, no.2, pp.193-196, 2014 (SCI-Expanded)
2014
2014PP-016 ECULIZUMAB PLUS CYCLOSPORIN TREATMENT FOR PAROXYSMAL NOCTURNAL HEMOGLOBINURIA FOLLOWED BY SUCCESSFUL ALLOGENEIC TRANSPLANTATION
Unal A., Akyol G., Kaynar L., Karakus E., Keklik M., Pala I., et al.
LEUKEMIA RESEARCH , vol.38, pp.32, 2014 (SCI-Expanded)
2014
2014The Coincidence of Familial Mediterranean Fever and Hypereosinophilia in a Patient with Hereditary Elliptocytosis
KEKLİK M., ÜNAL A., Sivgin S., KONTAŞ O., Eroglu E., YILMAZ S., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.30, pp.138-141, 2014 (SCI-Expanded)
2014
2014Detection of Acute Lymphoblastic Leukemia Involvement in Pleural Fluid in an Adult Patient with Ataxia Telangiectasia by Flow Cytometry Method
KEKLİK M., KÖKER M. Y., Sivgin S., Camlica D., Pala C., Cetin M., et al.
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION
, vol.30, pp.73-76, 2014 (SCI-Expanded)
2014
2014Prognostic importance of single-nucleotide polymorphisms in IL-6, IL-10, TGF-β1, IFN-γ, and TNF-α genes in chronic phase chronic myeloid Leukemia
Pehlivan M., Sahin H. H., PEHLİVAN S., Ozdilli K., Kaynar L., Oguz F. S., et al.
Genetic Testing and Molecular Biomarkers
, vol.18, no.6, pp.403-409, 2014 (SCI-Expanded)
2014
2014Investigation of Epstein-Barr Virus and Parvovirus B19 DNA in Ailogeneic Stem Cell Transplant Patients
ATALAY M. A., GÖKAHMETOĞLU S., Durmaz S., Kandemir I., Saǧlam D., KAYNAR L., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.31, no.2, pp.155-160, 2014 (SCI-Expanded)
2014
2014Diarrhea in peripheral stem cell transplant recipients: a developing country's experience
Pala C., KAYNAR L., Buyukoglan R., Kurnaz F., Metan G., Yazar S., et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
, vol.8, no.5, pp.635-641, 2014 (SCI-Expanded)
2014
2014Nuclear factor-kappa B ligand and osteoprotegerin levels in serum and gingival crevicular fluid in patients with bone metastases treated with zoledronic acid
Inanc M., KAYNAR L., Enhos S., Pala C., Karaca H., Berk V., et al.
MEDICAL ONCOLOGY
, vol.31, no.3, 2014 (SCI-Expanded)
2014
2014A rare but severe complication of filgrastim in a healthy donor: Splenic rupture
AKYOL G., Pala C., Yildirim A., Keklika M., Demir K., Dortdudak S., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.50, no.1, pp.53-55, 2014 (SCI-Expanded)
2014
2014The diagnostic value of the glactomannan and (1, 3)- beta-D-glucan in diagnosis of invasive aspergillosis İnvazi̇v aspergi̇llozun tanisinda (1,3)-beta-D glukan ve galaktomannanin tanisal deǧeri̇
Hörmet Ö. H., Koç A. N., Atalay M. A., Eser B., Yıldız O., Kaynar L.
Nobel Medicus
, vol.10, no.2, pp.44-49, 2014 (SCI-Expanded)
2014
2014Comparison of chemotherapy and hematopoietic stem cell transplantation pre and postterm DMFT scores: A preliminary study
Ertas E. T., Kurnaz F., Zorba Y., KOÇYİĞİT İ., Sisman Y., KAYNAR L., et al.
NIGERIAN JOURNAL OF CLINICAL PRACTICE
, vol.17, no.1, pp.32-37, 2014 (SCI-Expanded)
2014
2014Ibrutinib: From Molecule to Medicine
Ayyildiz O., Demirkan F., Goker H., Haznedaroglu I. C., Ilhan O., Kaynar L., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.24, no.3, pp.4-14, 2014 (SCI-Expanded)
2013
2013Langerhans cell sarcoma of the nasopharynx: a rare case
KEKLİK M., Sivgin S., KONTAŞ O., ABDÜLREZZAK Ü., KAYNAR L., ÇETİN M.
SCOTTISH MEDICAL JOURNAL
, vol.58, no.4, 2013 (SCI-Expanded)
2013
2013Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant
EROĞLU C., Pala C., KAYNAR L., YARAY K., AKSÖZEN M. T., Bankir M., et al.
LEUKEMIA & LYMPHOMA
, vol.54, no.11, pp.2474-2479, 2013 (SCI-Expanded)
2013
2013The Impact of Pretransplant Hypoalbuminemia on Survival in patients With Leukemia Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT): A Nutritional Problem?
Sivgin S., Baldane S., Ozenmis T., KEKLİK M., KAYNAR L., Kurnaz F., et al.
TRANSPLANTATION PROCEEDINGS
, vol.45, no.9, pp.3371-3374, 2013 (SCI-Expanded)
2013
2013The effect of volume replacement during therapeutic leukapheresis on white blood cell reduction in patients with extreme leukocytosis
Kurnaz F., Sivgin S., Pala C., Yildirim R., Baldane S., KAYNAR L., et al.
TRANSFUSION
, vol.53, no.11, pp.2629-2634, 2013 (SCI-Expanded)
2013
2013Cardiac effects of chronic graft-versus-host disease after stem cell transplantation
DOĞAN A., Dogdu O., Ozdogru I., Yarlioglues M., KALAY N., İNANÇ M. T., et al.
Texas Heart Institute Journal
, vol.40, no.4, pp.428-434, 2013 (SCI-Expanded)
2013
2013Changes in CD34+cell count in peripheral blood after whole blood donation
Pala C., Mumcuoglu H., Kurnaz F., Sivgin S., KAYNAR L., KEKLİK M., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.49, no.2, pp.259-262, 2013 (SCI-Expanded)
2013
2013The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload
Sivgin S., Baldane S., AKYOL G., KEKLİK M., KAYNAR L., Kurnaz F., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.49, no.2, pp.295-301, 2013 (SCI-Expanded)
2013
2013Can low-dose preemptive valganciclovir replace standard intravenous ganciclovir treatment in recipients of allogeneic stem cell transplantation?
KAYNAR L., Metan G., GÖKAHMETOĞLU S., Kurnaz F., Mumcuoǧlu H., ÖZTÜRK A., et al.
JOURNAL OF CHEMOTHERAPY
, vol.25, no.5, pp.286-291, 2013 (SCI-Expanded)
2013
2013The effect of diabetes mellitus and end-stage renal disease on the number of CD34+ cells in the blood
Pala C., Altun I., KÖKER M. Y., Kurnaz F., Sivgin S., KOÇYİĞİT İ., et al.
ANNALS OF HEMATOLOGY
, vol.92, no.9, pp.1189-1194, 2013 (SCI-Expanded)
2013
2013Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment
Kanda J., KAYNAR L., Kanda Y., Prasad V., Parikh S., Lan L., et al.
BONE MARROW TRANSPLANTATION
, vol.48, no.7, pp.926-931, 2013 (SCI-Expanded)
2013
2013The management of hyperleukocytosis in an adult patient with acute lymphoblastic leukemia and ataxia-telangiectasia
KEKLİK M., Sivgin S., Kalin B. S., AKYOL G., Pala C., Solmaz M., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.48, no.3, pp.293-295, 2013 (SCI-Expanded)
2013
2013The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: A single center experience from Turkey
Sivgin S., Karakus E., KAYNAR L., Kurnaz F., Pala C., KEKLİK M., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.48, no.3, pp.315-320, 2013 (SCI-Expanded)
2013
2013The results of therapeutic plasma exchange in patients with severe hyperthyroidism: A retrospective multicenter study
KEKLİK M., KAYNAR L., Yilmaz M., Sivgin S., Solmaz M., Pala C., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.48, no.3, pp.327-330, 2013 (SCI-Expanded)
2013
2013Treatment with plasma exchange may serve benefical effect in patients with severe hyperbilirubinemia: A single center experience
KEKLİK M., Sivgin S., KAYNAR L., Pala C., Solmaz M., Cetin M., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.48, no.3, pp.323-326, 2013 (SCI-Expanded)
2013
2013Coincidence of three solid tumors in a patient with multiple myeloma
KEKLIK M., ŞIVGIN S., DENİZ K., KARACA H., KONTAŞ O., BALKANLI S., et al.
CHINESE MEDICAL JOURNAL
, vol.126, no.6, pp.1186-7, 2013 (SCI-Expanded)
2013
2013Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases
Metan G., Demiraslan H., KAYNAR L., ZARARSIZ G., Alp E., Eser B.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES
, vol.17, no.2, pp.143-149, 2013 (SCI-Expanded)
2013
2013Risk factors influencing mortality related to <i>Stenotrophomonas maltophilia</i> infection in hematology-oncology patients
Demiraslan H., Sevim M., Pala Ç., Durmaz S., Berk V., KAYNAR L., et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY
, vol.97, no.3, pp.414-420, 2013 (SCI-Expanded)
2013
2013Pretransplant iron overload may be associated with increased risk of invasive fungal pneumonia (IFP) in patients that underwent allogeneic hematopoietic stem cell transplantation (alloHSCT)
Sivgin S., Baldane S., KAYNAR L., Kurnaz F., Pala C., Sivgin H., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.48, no.1, pp.103-108, 2013 (SCI-Expanded)
2013
2013What is the role of the (1 → 3)-β-D-glucan assay in the screening of patients undergoing autologous haematopoietic stem-cell transplantation?
Metan G., KOÇ A., KAYNAR L., ATALAY M. A., ÖZTÜRK A., Eser B., et al.
Mycoses
, vol.56, no.1, pp.34-38, 2013 (SCI-Expanded)
2013
2013Three cases of fungemia caused by Blastoschizomyces capitatus Blastoschizomyces capitatus'un neden olduǧu üç fungemi olgusu
KOÇ A., ÇOPUR ÇİÇEK A., KAYNAR L., Sav H., Kasap Tekinsen F. F., ATALAY M. A.
Mikrobiyoloji Bulteni
, vol.47, no.4, pp.734-741, 2013 (SCI-Expanded)
2013
2013Encephalitozoon intestinalis: A rare cause of diarrhea in an allogeneic hematopoietic stem cell transplantation (HSCT) recipient complicated by albendazole-related hepatotoxicity Allojenik hematopoietik kök hücre nakli alıcısında albendazol tedavisi sırasında gelişen hepatotoksisite ile komplike olmuş nadir bir diare etkeni: Encephalitozoon intestinalis
Şivgin S., Eser B., KAYNAR L., Kurnaz F., Şivgin H., Yazar S., et al.
Turkish Journal of Hematology
, vol.30, no.2, pp.204-208, 2013 (SCI-Expanded)
2012
2012Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?
ÖZKAN M., Sivgin S., KOÇYİĞİT İ., Emirogullari F., Dikilitas M., KAYNAR L., et al.
Asia-Pacific Journal of Clinical Oncology
, vol.8, no.3, 2012 (SCI-Expanded)
2012
2012P-39 LIPID APHAERESIS TREATMENT IN TWIN PREGNANT PATIENT WITH FAMILIAL HYPERCHOLESTEROLEMIA
Pala C., Keklik M., Sivgin S., Akyol G., Kaynar L., Solmaz M., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.47, pp.39-40, 2012 (SCI-Expanded)
2012
2012Research on and clinical importance of duplications in various chromosomal regions in addition to Philadelphia chromosome in chronic myeloid leukemia
Sever T., Kilicarslan C., Pehlivan M., KAYNAR L., Yilmaz M., Eser B., et al.
JOURNAL OF BUON
, vol.17, no.3, pp.490-496, 2012 (SCI-Expanded)
2012
2012Can bacteraemia lead to false positive results in 1,3-beta-d-glucan test? Analysis of 83 bacteraemia episodes in high-risk patients for invasive fungal infections
Metan G., Nedret Koc A., Aĝkuş Ç., Kaynar L., Alp E., Eser B.
Revista Iberoamericana de Micologia
, vol.29, no.3, pp.169-171, 2012 (SCI-Expanded)
2012
2012What should be the optimal cut-off of serum 1,3-β-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?
Metan G., Nedret Koç A., ATALAY M. A., KAYNAR L., ÖZTÜRK A., Alp E., et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
, vol.44, no.5, pp.330-336, 2012 (SCI-Expanded)
2012
2012Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)
Sivgin S., Eser B., Bahcebasi S., KAYNAR L., Kurnaz F., Uzer E., et al.
ANNALS OF HEMATOLOGY
, vol.91, no.5, pp.743-749, 2012 (SCI-Expanded)
2012
2012ABO and Rh Blood Group Distribution in Kayseri Province, Turkey
Torun Y. A., KAYNAR L., KARAKÜKCÜ Ç., Yay M., Kurnaz F., Mutlu H., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.29, no.1, pp.97-98, 2012 (SCI-Expanded)
2012
2012Evaluation of coagulation and fibrinolytic parameters in adult onset GH deficiency and the effects of GH replacement therapy: A placebo controlled study
Cakir I., Tanriverdi F., Karaca Z., KAYNAR L., Eser B., ÜNLÜHİZARCI K., et al.
Growth Hormone and IGF Research
, vol.22, no.1, pp.17-21, 2012 (SCI-Expanded)
2012
2012Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation
Sivgin S., Baldane S., KAYNAR L., Kurnaz F., PALA Ç., Sivgin H., et al.
NEOPLASMA
, vol.59, no.2, pp.183-190, 2012 (SCI-Expanded)
2012
2012P-21 THE COMPARISON OF GRANULOCYTE COLONY-STIMULATING FACTORS FOR MOBILISATION IN PATIENTS WHO UNDERWENT AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT): A SINGLE CENTER EXPERIENCE
Sivgin S., Karakus E., Kaynar L., Kurnaz F., Pala C., Keklik M., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.47, pp.31, 2012 (SCI-Expanded)
2012
2012P-41 TREATMENT OF HYPERBILIRUBINEMIA WITH PLASMA EXCHANGE IN ERCIYES UNIVERSITY
Keklik M., Sivgin S., Pala C., Solmaz M., Kaynar L., Cetin M., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.47, pp.40-41, 2012 (SCI-Expanded)
2012
2012EFFICACY OF ROYAL JELLY ON METHOTREXATE-INDUCED SYSTEMIC OXIDATIVE STRESS AND DAMAGE TO SMALL INTESTINE IN RATS
KAYNAR L., Cetin A., Hacioglu S. K., Eser B., KOÇYİĞİT İ., Canöz Ö., et al.
AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES
, vol.9, no.3, pp.412-417, 2012 (SCI-Expanded)
2012
2012Successful treatment of homozygous familial hypercholesterolemia using cascade filtration plasmapheresis Homozigot ailevi hiperkolesterolemi'nin 'cascade filtration' plazmaferezi ile başarılı tedavisi
KARDAŞ F., ÇETİN A., Solmaz M., Büyükoǧlan R., KAYNAR L., Kendirci M., et al.
Turkish Journal of Hematology
, vol.29, no.4, pp.334-341, 2012 (SCI-Expanded)
2012
2012P-56 THERAPEUTIC APHERESIS DUE TO SEVERE HYPERTHYROIDISM
Keklik M., Kaynar L., Pala C., Sivgin S., Aribas S., Akyol G., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.47, pp.47, 2012 (SCI-Expanded)
2012
2012Use of Cyclosporine Is Associated with the Increase in Pre-Engraftment Syndrome After Myeloablative Dual Cord Blood Transplantation
Kanda J., Kaynar L., Kanda Y., Prasad V., Parikh S., Rizzieri D., et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , vol.18, pp.332, 2012 (SCI-Expanded)
2012
2012P-43 THE CONTROL OF ACUTE LYMPHOBLASTIC LEUKAEMIA CAUSED HYPERLEUKOCYTOSIS WITH LEUKOPHERESIS ON AN ADULT ATAXIA-TELANGIECTASIA PATIENT
Keklik M., Sivgin S., Kalin B., Akyol G., Pala C., Solmaz M., et al.
TRANSFUSION AND APHERESIS SCIENCE , vol.47, pp.41, 2012 (SCI-Expanded)
2011
2011Venous Thromboembolism Risk and Thromboprophylaxis Among Hospitalized Patients: Data From the Turkish Arm of the ENDORSE Study
Ongen G., Yilmaz A., Cirak A., Ersoy C., ERDEN B. F., Altintaş F., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
, vol.17, no.5, pp.539-545, 2011 (SCI-Expanded)
2011
2011Impaired Aortic Elastic Properties in Patients with Chronic Graft-versus-Host Disease
Dogdu O., Kaya M. G., Yarlioglues M., DOĞAN A., Ardic I., ELÇİK D., et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
, vol.28, no.9, pp.1011-1018, 2011 (SCI-Expanded)
2011
2011A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin
Kurnaz F., Metan G., Coskun R., KAYNAR L., Eser B., DOĞANAY M.
TROPICAL DOCTOR
, vol.41, no.3, pp.181-182, 2011 (SCI-Expanded)
2011
2011Investigation of Epstein Barr virus serology and DNA in bone marrow transplant recipients
İNCİ M., GÖKAHMETOĞLU S., KAYNAR L., ERCAL B., DURMAZ S., BÜYÜKOĞLAN R.
AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH , vol.5, no.5, pp.496-500, 2011 (SCI-Expanded)
2011
2011PP-221: IMPAIRED AORTIC ELASTIC PROPERTIES IN PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE
Dogdu O., Kaya M., Yarlioglues M., Dogan A., Ardic I., Elcik D., et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY , vol.147, pp.150, 2011 (SCI-Expanded)
2010
2010Two cases of H1N1 influenza infection as the initial presentation of acute leukemia Akut löseminin başlangıç bulgusu olarak H1N1 influenza enfeksiyonu olan iki vaka
Kaynar L., Şivgin S., Başpinar O., Kurnaz F., Yildirim A., Metan G.
Turkish Journal of Medical Sciences
, vol.41, no.2, pp.363-367, 2010 (SCI-Expanded)
2010
2010Acute renal failure after myeloablative allogeneic hematopoietic stem cell transplantation: Incidence, risk factors, and relationship with the quantity of transplanted cells
TOKGÖZ B., KOÇYİĞİT İ., Polat G., Eser B., Unal A., KAYNAR L., et al.
Renal Failure
, vol.32, no.5, pp.547-554, 2010 (SCI-Expanded)
2010
2010Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients The ENDORSE Global Survey
Bergmann J., Cohen A. T., Tapson V. F., Goldhaber S. Z., Kakkar A. K., Deslandes B., et al.
THROMBOSIS AND HAEMOSTASIS
, vol.103, no.4, pp.736-748, 2010 (SCI-Expanded)
2010
2010Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients.
Kakkar A. K., Cohen A. T., Tapson V. F., Bergmann J., Goldhaber S. Z., Deslandes B., et al.
Annals of surgery
, vol.251, no.2, pp.330-8, 2010 (SCI-Expanded)
2010
2010Expression of WT1 gene in multiple myeloma patients at diagnosis: Is WT1 gene expression a useful marker in multiple myeloma?
Saatci C., Caglayan A. O., KOÇYİĞİT İ., AKALIN H., KAYNAR L., ALTUNTAŞ F., et al.
Hematology
, vol.15, no.1, pp.39-42, 2010 (SCI-Expanded)
2010
2010Pancreatic Masses Not All of Them are Pancreatic Adenocarcinoma Differential Diagnosis
KAYNAR L., YURCİ M. A., KURNAZ F., KARADAĞ M., ESER B., SOYUER I., et al.
Türkiye Klinikleri Tıp Bilimleri Dergisi
, vol.30, no.5, pp.1772-1776, 2010 (SCI-Expanded)
2009
2009Rhabdomyolysis in a healthy peripheral blood stem cell donor following mobilization with filgrastim
Hacioglu S., ALTUNTAŞ F., KAYNAR L., Sari I., Patiroglu T., Cetin M.
Transfusion Medicine and Hemotherapy
, vol.36, no.2, pp.135-137, 2009 (SCI-Expanded)
2009
2009Effects of imatinib mesylate on Renin-Angiotensin System (RAS) activity during the clinical course of chronic myeloid leukaemia
Sayitoglu M., Haznedaroǧlu I. C., Hatirnaz O., Erbilgin Y., Aksu S., Koca E., et al.
Journal of International Medical Research
, vol.37, no.4, pp.1018-1028, 2009 (SCI-Expanded)
2008
2008Detection and quantification of cytomegalovirus in bone marrow transplant recipients by real time PCR and pp65 antigenemia
GÖKAHMETOĞLU S., KAYNAR L., ALTUNTAŞ F., YILDIZ O., Cetin M., KOÇYİĞİT İ.
Saudi Medical Journal
, vol.29, no.11, pp.1673-1675, 2008 (SCI-Expanded)
2008
2008An usual case of acute brucellosis presenting with coombs-positive autoimmune hemolytic anemia
Sari I., KOÇYİĞİT İ., ALTUNTAŞ F., KAYNAR L., Eser B.
Internal Medicine
, vol.47, no.11, pp.1043-1045, 2008 (SCI-Expanded)
2008
2008Comparison of plateletpheresis on the Fenwal Amicus and Fresenius Com.Tec cell separators
ALTUNTAŞ F., Sari I., Kocyigit I., KAYNAR L., Hacioglu S., Ozturk A., et al.
Transfusion Medicine and Hemotherapy
, vol.35, no.5, pp.368-373, 2008 (SCI-Expanded)
2008
2008Achondroplasia associated with gonadal dysgenesis
Gokce C., Atabek M., KAYNAR L., Torun E., Kurtoglu S., BAYRAM F.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, vol.36, no.3, pp.605-608, 2008 (SCI-Expanded)
2008
2008Therapeutic plasma exchange in patients with neurologic diseases: Retrospective multicenter study
KAYNAR L., ALTUNTAŞ F., Aydogdu I., Turgut B., Kocyigit I., Hacioglu S. K., et al.
Transfusion and Apheresis Science
, vol.38, no.2, pp.109-115, 2008 (SCI-Expanded)
2008
2008A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis
Sari I., Altuntas F., Hacioglu S., Kocyigit I., Sevinc A., Sacar S., et al.
AMERICAN JOURNAL OF HEMATOLOGY
, vol.83, no.4, pp.334-339, 2008 (SCI-Expanded)
2008
2008Disturbance of pro-oxidative/antioxidative balance in allogeneic peripheral blood stem cell transplantation
Sari I., ÇETİN A., KAYNAR L., Saraymen R., Hacioglu S. K., ÖZTÜRK A., et al.
Annals of Clinical and Laboratory Science
, vol.38, no.2, pp.120-125, 2008 (SCI-Expanded)
2008
2008Role of Grape Seed Extract on Methotrexate Induced Oxidative Stress in Rat Liver
ÇETİN A., KAYNAR L., KOÇYİĞİT İ., Hacioglu S. K., Saraymen R., ÖZTÜRK A., et al.
AMERICAN JOURNAL OF CHINESE MEDICINE
, vol.36, no.5, pp.861-872, 2008 (SCI-Expanded)
2007
2007Comparison of the Fenwal Amicus and Fresenius Com.Tec cell separators for autologous peripheral blood progenitor cell collection
ALTUNTAŞ F., Kocyigit I., Ozturk A., KAYNAR L., Sari I., Oztekin M., et al.
TRANSFUSION AND APHERESIS SCIENCE
, vol.36, no.2, pp.159-167, 2007 (SCI-Expanded)
2006
2006COMPARISON OF DIFFERENT CONDITIONING REGIMENS USED IN RELAPSE AGRESSIVE NON-HODGKIN LYMPHOMA: ICE-CNV-BEAM
Ünal A., Sarı I., Kaynar L., Altuntaş F., Eser B., Özkan M., et al.
ANNALS OF ONCOLOGY , vol.17, no.9, pp.201, 2006 (SCI-Expanded)
2006
2006Effects of 3 years of intravenous pamidronate treatment on bone markers and one mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG)
BAYRAM F., Tanriverdi F., Kurtoǧlu S., Atabek M. E., Kula M., KAYNAR L., et al.
Journal of Pediatric Endocrinology and Metabolism
, vol.19, no.3, pp.275-279, 2006 (SCI-Expanded)
Articles Published in Other Journals
2024
2024Follow-up of patients given isoniazid prophylaxis in multiple myeloma patients underwent autologous stem cell transplantation
AKYOL G., KEKLİK M., KAYNAR L., ÜNAL A.
Journal of Current Hematology & Oncology Research , vol.2, no.3, pp.63-66, 2024 (Peer-Reviewed Journal)
2024
2024A case of Turner's syndrome, factor 5 Leiden, and fibrinogen deficiency associated with congenital aortic stenosis complicated by aortic aneurysm and aortic regurgitation
Öteyaka E., Kaynar L., Ugurlucan H. E. M., Türkoğlu H.
COR ET VASA
, vol.66, no.3, pp.378-379, 2024 (ESCI)
2024
2024Does early granulocyte colony-stimulating factor administration in autologous peripheral blood stem cell transplantation shorten the duration of hospitalization in patients with multiple myeloma?
KEKLİK M., TOPAL L., ÇELİK S., KAYNAR L.
Journal of Current Hematology & Oncology Research , vol.2, no.2, pp.41-46, 2024 (Peer-Reviewed Journal)
2024
2024Get two with one: bevacizumab treatment in hereditary hemorrhagic telangiectasia with concomitant cirrhosis
Çelik S., Kaynar L.
Journal of Current Hematology & Oncology Research , vol.2, no.1, pp.20-21, 2024 (Peer-Reviewed Journal)
2024
2024The Predictors of COVID-19 Immunogenicity Elicited by Vaccines Against SARS-CoV-2 in Stem Cell Transplant Recipients
Elbahr U., Erdem H., Ankarali H., Reyes C., Pastrana J., Vineeth C., et al.
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI
, vol.29, no.2, pp.259-268, 2024 (ESCI)
2023
2023Prospective Evaluation of Critically İll Patients with Therapeutic Plasma Exchange in Medical İntensive Care Unit
ÇALIŞKAN M., TEMEL Ş., KARAOĞLU E. N., YILDIRIM M., ASLAN M., KAYNAR L., et al.
Eurasian Journal of Critical Care , vol.5, no.3, pp.79-83, 2023 (Peer-Reviewed Journal)
2023
2023Hereditary hyperferritinemia cataract syndrome with iron deficiency : a case report
Abedi A. H., Çelik S., Özçelik Yılmaz Z. D., Güven Z. T., Kaynar L.
Journal of Current Hematology & Oncology Research , vol.1, no.4, pp.107-108, 2023 (Peer-Reviewed Journal)
2023
2023A rare case of acute basophilic leukemia
ÇELİK S., KEKLİK M., KONTAŞ O., KÖKER M. Y., KAYNAR L.
Journal of Current Hematology & Oncology Research , vol.1, no.3, pp.73-75, 2023 (Peer-Reviewed Journal)
2023
2023Second Allogeneic Stem Cell Transplantation in Acute Leukemia with Post-Transplantation Relapse
Güven Z. T., Çelik S., Eser B., Çetin M., Ünal A., Kaynar L.
Medical records-international medical journal (Online) , vol.5, no.3, pp.455-459, 2023 (Peer-Reviewed Journal)
2023
2023A retrospective analysis on mucormycosis in patients with hematological diseases: a single center experience from Turkey
Yıldızhan E., Güven Z. T., Kaynar L.
JOURNAL OF HEALTH SCIENCES AND MEDICINE , vol.6, no.3, pp.635-642, 2023 (Peer-Reviewed Journal)
2023
2023Donor cell leukemia after allogeneic hematopoietic stem cell transplantation: a case report
Abedi A. H., Çelik S., Özçelik Yılmaz Z. D., Güven Z. T., Akalın H., Kaynar L.
JOURNAL OF CURRENT HEMATOLOGY AND ONCOLOGY RESEARCH , vol.1, no.2, pp.47-48, 2023 (Peer-Reviewed Journal)
2023
2023DETERMINATION OF GENOTYPES IN CYTOMEGALOVIRUS (CMV) STRAINS OBTAINED FROM PEDIATRIC AND ADULT IMMUNOCOMPROMISED PATIENTS
Coşkun A., Gökahmetoğlu S., Özmen P., Çevik Ş., Karakükcü M., Kaynar L., et al.
JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES
, vol.7, no.1, pp.270-276, 2023 (ESCI)
2023
2023Adult Onset Langerhans Cell Histiocytosis: A Single Center Experience
Çelik S., Güven Z. T., Aşık O., Keklik M., Kaynar L., Eser B., et al.
Medical records-international medical journal (Online) , vol.5, no.1, pp.59-64, 2023 (Peer-Reviewed Journal)
2022
2022Comparison of ATRA-Arsenic Trioxide and ATRAIdarubicin in Patients with Acute Promyelocytic Leukemia
Çelik S., Ünal A., Şahin R., Güven Z. T., Baydar M., Keklik M., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, vol.6, no.3, pp.79-84, 2022 (Peer-Reviewed Journal)
2022
2022Evaluation of refeeding hypophosphatemia frequency, risk factors, and nutritional status during stem cell transplantation in patients with hematologic malignancy
Ergül S. Ş., Sahin G. G., Ozer N. T., Kaynar L., Celik S., Gündoğan K.
CLINICAL NUTRITION ESPEN
, vol.51, pp.385-390, 2022 (ESCI)
2022
2022Bacteremia in Hematopoietic Stem Cell Recipients Receiving Fluoroquinolone Prophylaxis: Incidence, Resistance, and Risk Factors
Eryılmaz Eren E., İzci F., Türe Yüce Z., Sağıroğlu P., Kaynar L., Ulu Kılıç A.
Infection and Chemotherapy
, vol.54, no.3, pp.446-455, 2022 (ESCI)
2022
2022Cytomegalovirus (CMV) and Hepatitis B (HBV) Reactivation During Autologous Stem Cell Transplantation: A Single-center Experience
Gemici A., Beköz H. S., Sevindik Ö., Sadri S., Serin İ., Erol V. B., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, vol.6, no.2, pp.38-44, 2022 (Peer-Reviewed Journal)
2022
2022Toxoplasmic encephalitis after allogeneic hematopoietic stem cell transplantation
İzci F., Mumcu N., Kalın Ünüvar G., Ulu Kılıç A., Kaynar L.
NORTHERN CLINICS OF ISTANBUL = ISTANBUL KUZEY KLINIKLERI
, vol.9, no.3, pp.282-285, 2022 (ESCI)
2021
2021The Effect of Blood Groups on Infection and Prognosis of SARS-CoV-2
Aslaner H., Gökçek M. B., Benli A. R., Baydemir R., Güven Z., Akyol G., et al.
Medical records-international medical journal (Online)
, vol.3, no.3, pp.191-196, 2021 (Peer-Reviewed Journal)
2021
2021Acute Myeloid Leukemia After the Treatment of Invasive Ductal Breast Carcinoma
GÜVEN Z. T., ÇELİK S., KEKLİK M., ÜNAL A., KAYNAR L.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları
, vol.5, no.3, pp.66-69, 2021 (Peer-Reviewed Journal)
2021
2021Evaluation of Epileptic Seizures Developed During Hematopoietic Stem Cell Transplantation: A Single Center Experience
ÇELİK S., GÜVEN Z. T., ÖZSOY N. K., GÜNAY A., KEKLİK M., KAYNAR L., et al.
ACTA ONCOLOGICA TURCICA
, vol.54, pp.40-50, 2021 (Peer-Reviewed Journal)
2021
2021Retrospective evaluation of patients with primary mediastinal large B-Cell lymphoma: Real life experience
GÜVEN Z. T., ÇELİK S., KAYNAR L., KEKLİK M., ESER B., ÇETİN M., et al.
Annals of Medical Research
, vol.28, no.10, pp.1830-1834, 2021 (Peer-Reviewed Journal)
2020
2020ACİL SERVİSE NÖTROPENİK ATEŞ İLE BAŞVURAN HASTALARIN ARAŞTIRILMASI
İPEK Ö. F., AVŞAROĞULLARI Ö. L., KAYNAR L., TAŞLIDERE B.
Aksaray Üniversitesi Tıp Bilimleri Dergisi , vol.1, no.2, pp.10-14, 2020 (Peer-Reviewed Journal)
2020
2020Therapeutic Plasma Exchange in G6PD Deficient Patient Complicated with Intravascular Hemolysis: A Case Report
Turak E., Ibrahim R., Özturk F., Demir K., Karamustafaoglu M., Kahraman V., et al.
ERCIYES MEDICAL JOURNAL
, vol.42, no.2, pp.223-225, 2020 (ESCI)
2020
2020Remisyon İndüksiyon Kemoterapisinde Posakonazol Proflaksisi Ne Zaman Başlanmalı? When Should Posaconazol Prophylaxıs in Remision Induction Chemotherapy Be Started?
EREN E., ULU KILIÇ A., KAYNAR L.
Journal of Anatolian Medical Research , vol.5, no.2, pp.1-5, 2020 (Peer-Reviewed Journal)
2020
2020Chemotherapy-induced Toxic Leukoencephalopathy
Yetkin M. F., Göl M. F., Köse E. G., Kaynar L.
TURKISH JOURNAL OF NEUROLOGY
, vol.26, no.1, pp.49-52, 2020 (ESCI)
2020
2020Assessment of Post-transplantation Liver Function Tests in Patients Undergoing Allogeneic Stem Cell Transplantation
KIZILTEPE M., YILDIZHAN E., ÜNAL A., ÇETİN M., ESER B., KAYNAR L.
ERCIYES MEDICAL JOURNAL
, vol.42, no.1, pp.60-65, 2020 (ESCI)
2020
2020Current Approach to Neutropenic Enterocolitis
ERTÜRK Ü., ERMİŞ TURAK E., KAYNAR L., FADEL E.
ERCIYES MEDICAL JOURNAL
, vol.42, no.2, pp.119-120, 2020 (ESCI)
2020
2020The Outcome of Fungal Pneumonia with Hematological Cancer
Eren E., ALP MEŞE E., Cevahir F., Tok T., ULU KILIÇ A., KAYNAR L., et al.
INFECTION AND CHEMOTHERAPY
, vol.52, no.4, pp.530-538, 2020 (ESCI)
2019
2019The Importance of CMV PCR Monitoring in Hematologic Malignant Patients Take Chemotherapy
GÜVEN Z. T., DÜNDAR T., ÇELİK S., KAYNAR L.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.3, no.3, pp.60-66, 2019 (Peer-Reviewed Journal)
2019
2019HEREDİTER ANJİOÖDEMDE KISA DÖNEM DANAZOL PROFİLAKSİSİ İLE İMPLANT TEDAVİSİ: VAKA RAPORU
GÖNEN Z. B., DOĞRUEL F., YILMAZ ASAN C., KAYNAR L., ÇETİN M.
Selcuk Dental Journal
, vol.6, no.2, pp.190-195, 2019 (Peer-Reviewed Journal)
2019
2019New way in cancer therapy PD1 inhibitors at hematologic diseases
Akyol G., Kaynar L., Çetin M.
ERCIYES MEDICAL JOURNAL
, vol.41, no.1, pp.12-17, 2019 (Peer-Reviewed Journal)
2018
2018Cytokine release syndrome
Yıldızhan E., Kaynar L.
Journal of oncological sciences , vol.4, no.3, pp.134-141, 2018 (Scopus)
2018
2018Allojenik Kök Hücre Nakli Sonrası Nötropenik Dönem Takibinde Granülosit İnfüzyonunun Yeri
KENİ N., ÜNAL A., KAYNAR L., ESER B., birekul a., GÜVEN Z. T., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.2, no.2, pp.42-46, 2018 (Peer-Reviewed Journal)
2018
2018Hiperlipidemi Tedavisinde Terapötik Aferez
KAYNAR L., BAYRAM F.
Turkiye Klinikleri J Endocrin-Special Topics , vol.11, no.1, pp.76-82, 2018 (Peer-Reviewed Journal)
2018
2018Severe Herpes Zoster Ophtalmicus in an Immuncompromised Patient
Eren E., Kaynar L., Doğanay M.
ERCIYES MEDICAL JOURNAL
, vol.40, no.4, pp.240-241, 2018 (Peer-Reviewed Journal)
2017
2017Assessment of factors affecting engraftment after autologous stem cell transplantation
DOĞRUEL F., pala öztürk ç., albayrak m., KAYNAR L., ŞIVGIN S., ESER B., et al.
JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE
, vol.8, no.4, pp.332-335, 2017 (ESCI)
2017
2017Phenotype frequencies of blood group systems and alloantibodies to red blood cells in blood transfusion recipients in Kayseri (Turkey)
Torun Altuner Y., Kaynar L., Karakükçü Ç., Yay M., Ergül A. B., Turanoğlu C., et al.
Journal Of Turgut Ozal Medical Center
, vol.24, no.4, pp.434-436, 2017 (Peer-Reviewed Journal)
2017
2017Miyelodisplastik Sendromun Hipometile Edici Ajanlarla Tedavisi;Gerçek Hayat Verileri Tek Merkez Deneyimi Treatment of Myelodysplastic Syndrome with Hypomethylating Agents; Real Life Analysis, Single Center Experience
KENİ BEGENDİ N., UYSAL E., YILDIZHAN E., ERMİŞ TURAK E., KAYNAR L., ESER B., et al.
Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.1, no.2, pp.49-54, 2017 (Peer-Reviewed Journal)
2017
2017Akut Miyeloid Lösemide Epigenetik Değişiklikler ve Epigenetik Hedefli Tedaviler
MANDACI ŞANLI N., KAYNAR L.
Turkiye Klinikleri Journal of Hematology Special Topics , vol.10, no.1, pp.30-36, 2017 (Peer-Reviewed Journal)
2017
2017A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Metan G., Kaynar L., Yozgat N., Elmalı F., Kürkçüoglu C. A., Alp Meşe E., et al.
LE INFEZIONI IN MEDICINA : RIVISTA PERIODICA DI EZIOLOGIA, EPIDEMIOLOGIA, DIAGNOSTICA, CLINICA E TERAPIA DELLE PATOLOGIE INFETTIVE
, vol.25, no.1, pp.33-37, 2017 (Scopus)
2016
2016Significance of the T3151 T317L E255K AND Y253H BCR ABL gene mutations in Philadelphia positive Chronic Myeloid Leukemia patients
KIS C., PEHLİVAN S., ESER B., SEVER T., YILMAZ M., KAYNAR L., et al.
KSÜ Tıp Fakültesi Dergisi , vol.11, no.2, pp.14-23, 2016 (Peer-Reviewed Journal)
2016
2016Sitokin Salınım Sendromu
YILDIZHAN E., KAYNAR L.
Türkiye Klinikleri Hematoloji Özel Dergisi , vol.9, no.3, pp.65-75, 2016 (Peer-Reviewed Journal)
2016
2016Cytogenetic Features of Elderly Turkish Myelodysplastic Syndrome Patients
keklik m., büyükoğlan r., ŞIVGIN S., ESER B., KAYNAR L., ÇETİN M., et al.
ERCIYES MEDICAL JOURNAL
, vol.38, no.3, pp.95-98, 2016 (Scopus)
2016
2016BCR-ABL Negatif Kronik Miyeloid Lösemi, Kronik Nötrofilik Lösemi ve Kronik Eozinofilik Lösemi
Ermiş Turak E., Kaynar L.
Türkiye Klinikleri Hematoloji Özel Dergisi , vol.9, no.2, pp.24-33, 2016 (Peer-Reviewed Journal)
2016
2016Pulmonary infection caused by Talaromyces purpurogenus in a patient with multiple myeloma
Atalay M. A., Koç A. N., Akyol G., Çakır N., Kaynar L., Ulu Kılıç A.
LE INFEZIONI IN MEDICINA : RIVISTA PERIODICA DI EZIOLOGIA, EPIDEMIOLOGIA, DIAGNOSTICA, CLINICA E TERAPIA DELLE PATOLOGIE INFETTIVE
, vol.24, no.2, pp.153-157, 2016 (Scopus)
2016
2016A Flow Cytometric Scoring System in the Diagnosis of Mantle Cell Lymphoma
KEKLİK M., KÖKER M. Y., KORKMAZ S., ŞIVGIN S., KAYNAR L., ÇAMLICA D., et al.
ERCIYES MEDICAL JOURNAL
, vol.38, no.1, pp.25-28, 2016 (Scopus)
2016
2016Response of Complex Undefined Hypereosinophilic Syndrome to Treatment with Imatinib
Yılmaz İ., Kaynar L., Tutar N., Pala Ç., Canöz Ö., Yıldırım A., et al.
TURKISH THORACIC JOURNAL
, vol.17, no.3, pp.118-121, 2016 (Scopus)
2016
2016Effects of Imatinib, Nilotinib, Dasatinib on VEGF and VEGFR-1 Levels in Patients with Chronic Myelogenous Leukemia
Yıldırım R., Sincan G., Pala Ç., Düdükçü M., Kaynar L., Urlu S. M., et al.
EUROPEAN JOURNAL OF GENERAL MEDICINE
, vol.13, no.2, pp.111-115, 2016 (ESCI)
2015
2015Biliary Obstruction Secondary to an Extramedullary Plasmacytoma of the Pancreas
Coskun Demet O., KAYNAR L., Ahmet Y.
ERCIYES MEDICAL JOURNAL
, vol.37, no.2, pp.75-77, 2015 (Scopus)
2015
2015Lipid Aferezi Güncel Yöntemler ve Klinik Kullanım Alanları
AKYOL G., KAYNAR L., SOLMAZ M.
Turkiye Klinikleri Journal of Hematology Special Topics , vol.8, no.1, pp.27-31, 2015 (Peer-Reviewed Journal)
2015
2015Pulmonary Extramedullary Hematopoiesis Mimicking Plasmacytoma in a Patient with Multiple Myeloma
BALDANE S., ŞIVGIN S., KAYNAR L., ÖZASLAN E., YILDIRIM A., CANÖZ Ö., et al.
Romanian Journal Of Internal Medicine
, vol.53, no.4, pp.355-358, 2015 (Scopus)
2015
2015Measurement of hair iron concentration as a marker of body iron content
ŞAHİN C., pala ç., KAYNAR L., Torun Y., ÇETİN A., KURNAZ F., et al.
Biomedical Reports
, vol.3, pp.383-387, 2015 (Scopus)
2014
2014A nightmare for haematology clinics extensively drug resistant XDR Acinetobacter baumannnii
Metan G., Öztürk Ç P., Kaynar L., Fa C., Alp Meşe E.
LE INFEZIONI IN MEDICINA : RIVISTA PERIODICA DI EZIOLOGIA, EPIDEMIOLOGIA, DIAGNOSTICA, CLINICA E TERAPIA DELLE PATOLOGIE INFETTIVE
, vol.22, no.4, pp.277-282, 2014 (Scopus)
2014
2014Usefulness of (1→3)-b-D glucan in early diagnosing Pneumocystis jirovecii pneumonia: A case report Utilità del (1→3)-b-D glucano nella diagnosi precoce di polmonite da Pneumocystis jirovecii: Un caso clinico
Atalay M. A., Koc A. N., Kaynar L., Inci M., Kasap Tekinsen F. F., Eser B.
Infezioni in Medicina
, vol.22, no.1, pp.57-61, 2014 (Scopus)
2013
2013An Acute Transverse Myelitis Attack after Total Body Irradiation A Rare Case
Keklik M., Kaynar L., Yiıldırım A., Şıvgın S., Eroğlu C., Cingöz Ş., et al.
CASE REPORTS IN HEMATOLOGY
, vol.2013, pp.1-4, 2013 (Peer-Reviewed Journal)
2013
2013Successful treatment of gastric relapse in multiple myeloma with bortezomib after autologous hematopoietic stem cell transplantation autoHSCT
ŞIVGIN S., BALDANE S., KAYNAR L.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
, vol.5, no.1, pp.2013006, 2013 (Scopus)
2012
2012Factors That Affect Survival in Patients with Allogeneic Hematopoetic Stem Cell Transplantation
Şahin C., Kaynar L., Kurnaz F., Pala C., Şıvgın S., Eser B., et al.
ERCIYES MEDICAL JOURNAL
, vol.34, no.4, pp.178-183, 2012 (ESCI)
2012
2012Predictive Value of Pretransplant Serum Lactate Dehydrogenase (LDH) Levels for Survival in Patients who have undergone Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT)
ŞIVGIN S., ÖzenmiŞ T., KAYNAR L., KURNAZ F., ŞIVGIN H., BALDANE S., et al.
Journal of Stem Cell Research Therapy , vol.2, no.01, pp.1-6, 2012 (Peer-Reviewed Journal)
2012
2012An Atypical Presentation of Brucellosis in a Patient with Isolated Thrombocytopenia Complicated with Upper Gastrointestinal Tract Bleeding
BALDANE S., ŞIVGIN S., Tahsin Sezgin A., KURNAZ F., Cigdem P., Muzaffer K., et al.
CASE REPORTS IN MEDICINE
, vol.2012, pp.1-4, 2012 (Scopus)
2012
2012Flow Cytometry Method as a Diagnostic Tool for Pleural Fluid Involvement in a Patient with Multiple Myeloma
Muzaffer K., Şıvgın S., Cigdem P., Eroğlu C., Gulsah A., Kaynar L., et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
, vol.4, no.1, pp.2012063, 2012 (Scopus)
2011
2011A case of pancytopenia and related findings complicating primary Sjögren's Syndrome Pansitopeni ve İlişkili Klinik Bulgularla Başvuran Primer Sjögren Sendromu Olgusu
Akar M., Yokus O., KAYNAR L., Kurnaz F., Eser B.
Erciyes Tip Dergisi
, vol.33, no.4, pp.345-348, 2011 (Scopus)
2011
2011Sıçanlarda Metotreksata Bağlı Karaciğer Hasarında Propolisin Olumlu Etkileri
Çetin A., Kaynar L., Eser B., Karadağ C., Saraymen B., Öztürk A., et al.
ACTA ONCOLOGICA TURCICA , vol.44, no.1, pp.18-23, 2011 (Peer-Reviewed Journal)
2010
2010Hematopoietik kök hücre nakli yapılan hastalarda akut böbrek hasarı Acute Kidney Injury after Hematopoietic Stem Cell Transplantation
Tokgöz B., Koçyiğit İ., Gülşah A., Eser B., Ünal A., Kaynar L., et al.
Turkish Journal of Nephrology
, vol.19, no.2, pp.102-107, 2010 (Peer-Reviewed Journal)
2010
2010Treatment Failure of Disseminated Trichosporon asahii Infection with Voriconazole in a Patient with Acute Myeloid Leukemia
Kurnaz F., Kaynar L., Doğan S., Eser B., Metan G.
ACTA ONCOLOGICA TURCICA , vol.15, pp.32-35, 2010 (Peer-Reviewed Journal)
2010
2010Belirsiz Serili Akut Lösemiler Tanı ve Tedavi Seçenekleri
KAYNAR L., ESER B.
Türkiye Klinikleri Hematoloji Özel Dergisi , vol.3, no.2, pp.158-162, 2010 (Peer-Reviewed Journal)
2010
2010Are university students a favorable target group for blood donation campaigns? Üniversite ög̈rencileri kan bag̈ış kampanyaları için uygun bir hedef kitle midir?
Eser B., Kurnaz F., KAYNAR L., Yay M., Şivgin S., ÜNAL A., et al.
Turkish Journal of Hematology
, vol.27, no.4, pp.275-281, 2010 (Scopus)
2009
2009Primary Brain T-cell Lymphoma Concomitant with CNS Tuberculosis in a Kidney Transplant Patient
Sipahioglu M., Altuntaş F., Aybal A., Ünal A., Kaynar L., Kontas O., et al.
ERCIYES MEDICAL JOURNAL
, vol.31, no.3, pp.256-260, 2009 (Scopus)
2008
2008The use of high-dose acyclovir in patients with hematological malignancies who develop herpes virus infections: Is it really safe?
Sarı I., Kaynar L., Koçyiğit İ., Altuntas F.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.25, no.4, pp.205-6, 2008 (Scopus)
2008
2008The use of high-dose acyclovir in patients with hematological malignancies who develop herpes virus infections: Is it really safe? hematolojik hastalǧ olan herpes virusu gelisen hastalarda yüksek doz asiklovir kullani(dotless). gerçekten güvenli mi?
Sari I., KAYNAR L., Ko̧yiǧit I., ALTUNTAŞ F.
Turkish Journal of Hematology
, vol.25, no.4, pp.205-206, 2008 (Scopus)
2008
2008Effects of industrial lead expossure on coagulation system Endüstriyel Kurşuna maruz kalmanιn pιhtιlaşma sistemi üzerine etkileri
MAZICIOĞLU M. M., KAYNAR L., ÇETİN A., Mumcuoǧlu H., Saraymen R., Karadaǧ Ö. K.
Erciyes Tip Dergisi
, vol.30, no.3, pp.150-156, 2008 (Scopus)
2008
2008The effect of grape seed extract on radiation-induced oxidative stress in the rat liver
Çetin A., Kaynar L., Koçyigit I., Hacioglu S., Saraymen R., Öztürk A., et al.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.19, no.2, pp.92-98, 2008 (Scopus)
2008
2008Ga-67 Uptake: a Predictor of Post-Therapy Active Residual Disease and Clinical Outcome in Patients with Diffuse Large Cell Lymphoma
Sari I., Kula M., Eser B., KAYNAR L., ALTUNTAŞ F., KOÇYİĞİT İ., et al.
ERCIYES MEDICAL JOURNAL
, vol.30, no.1, pp.8-13, 2008 (Scopus)
2008
2008Endüstriyel Kurşuna Maruz Kalmanın Pıhtılaşma Sistemi Üzerine Etkileri
MAZICIOĞLU M. M., KAYNAR L., ÇETİN A., mumcuoğlu h., SARAYMEN R., karadağ ö.
ERCIYES MEDICAL JOURNAL
, vol.30, no.3, pp.150-156, 2008 (Peer-Reviewed Journal)
2007
2007HEMATOPOETİK KÖK HÜCRE BİYOLOJİSİ
KOÇYİĞİT İ., KAYNAR L., ÇETİN M.
Türkiye Klinikleri Hematoloji Özel Dergisi , vol.1, no.2, pp.16-22, 2007 (Peer-Reviewed Journal)
2007
2007Koagülasyon Bozuklukları
ÜNAL A., KAYNAR L.
Türkiye Klinikleri Cerrahi Tıp Bilimleri Dergisi , vol.3, no.10, pp.36-40, 2007 (Peer-Reviewed Journal)
2007
2007Transfüzyon Öncesi Karşılaştırma Testleri
KAYNAR L., ALTUNTAŞ F.
Türkiye Klinikleri Dahili Tıp Bilimleri Dergisi , vol.3, no.36, pp.33-43, 2007 (Peer-Reviewed Journal)
2007
2007Isolated Microorganisms from Febrile Neutropenic Patients and Their Antimicrobial Susceptibility A Data of 2005
Demiraslan H., Yıldız O., Kaynar L., Altuntaş F., Eser B., Aygen B.
ERCIYES MEDICAL JOURNAL
, vol.29, no.5, pp.376-380, 2007 (Peer-Reviewed Journal)
2007
2007Mantle Cell Lenfoma
ÇETİN M., KAYNAR L.
Türkiye Klinikleri Dahili Tıp Bilimleri Dergisi , vol.4, no.2, pp.73-76, 2007 (Peer-Reviewed Journal)
2005
2005Malignant pleural mesothelioma with orbital metastasis
Altınbaş M., Özlem E., Coşkun H. Ş., Doğan H., Özkan M., Kaynar L., et al.
TURKISH JOURNAL OF CANCER
, vol.35, no.1, pp.35-37, 2005 (Peer-Reviewed Journal)
2004
2004Multipl Myeloma Tedavisinde Üç Farklı Konvansiyonel Kemoterapi Protokolünün Karşılaştırması: Tek Merkez Deneyimi
Altuntaş F., Kaynar L., Eser B., Sarı H. İ., Kaplan B., Özkan M., et al.
TURK ONKOLOJI DERGISI , vol.19, no.1, pp.9-14, 2004 (ESCI)
2004
2004Reifenstein sendromu: Olgu sunumu
GÖKCE C., ATABEK M. E., KAYNAR L., TORUN E., GÜNDOĞAN K., KURTOĞLU S., et al.
Endokrinolojide Yönelişler , vol.13, no.1, pp.25-27, 2004 (Peer-Reviewed Journal)
2003
2003Gebelik esnasında metastatik primer hiperparatiroidizm tanısı konulan tip 1 diabetes mellituslu bir olgu
GÖKCE C., KAYNAR L., DURAK A. C., KOÇ K., ŞAKRAK Ö., BAYRAM F.
Endokrinolojide Yönelişler , vol.12, no.5, pp.179-182, 2003 (Peer-Reviewed Journal)
2003
2003İmmün Trombositopenik Purpuralı Olguların Değerlendirilmesi: Bir Merkezin Sonuçları
ALTUNTAŞ F., KAYNAR L., ESER B., KÜÇÜK C., YÜCEL M. A., ÇETİN M., et al.
Türkiye Tıp Dergisi , vol.10, no.4, pp.152-156, 2003 (Peer-Reviewed Journal)
Papers Published in Refereed Scientific Meetings
2024
2024Is CMV PCR Monitoring Necessary for Hematological Malignancy during Chemotherapy?
GÜVEN Z. T., DÜNDAR T., ÇELİK S., KEKLİK M., ÜNAL A., GÖKAHMETOĞLU S., et al.
The 66th ASH Annual Meeting, United States Of America, 7 - 10 December 2024
2024
2024TÜRKİYE’DE HEREDİTER HEMORAJİK TELENJİEKTAZİ HASTALARININ TANI VE TEDAVİ SONUÇLARI: ÇOK MERKEZLİ KAYIT ÇALIŞMASI
UĞUR M. C., DEMİRCİ U., DEMİR A. M., DURAK E., ÖZMEN İBİŞ D., YOLCU A., et al.
50. Ulusal Hematoloji Kongresi, Turkey, 29 October 2024
2024
2024HIZLI SEYREDEN BİR TÜMORAL EVRE MİKOZİS FUNGOİDES OLGUSU
KEKLİK M., ÇINAR S. L., ŞİMŞEK R., KAYNAR L.
50. Ulusal Hematoloji Kongresi, Turkey, 29 October - 02 November 2024
2024
2024OTOLOG KÖK HÜCRE NAKLİ SONRASI GRAFT VERSUS HOST HASTALIĞI GELİŞEN HASTALARIN DEĞERLENDİRİLMESİ, ÇOK MERKEZLİ ÇALIŞMA
YİĞİT KAYA S., MUTLU Y. G., YILDIRIM M., SERİN İ., AVCI D. N., AKYOL G., et al.
50. Ulusal Hematoloji Kongresi, Turkey, 29 October 2024
2024
2024ALLOJENİK KÖK HÜCRE NAKLİ SONRASI HİPERKALSEMİ İLE SEYREDEN NADİR BİR PNEUMOCYSTİS JİROVECİİ PNÖMONİSİ VAKASI
ÖZALP Y. C., SHEHABI H., TEKİN M. G., YİĞİT KAYA S., BEKÖZ H. S., MARAL S., et al.
50. Ulusal Hematoloji Kongresi, Turkey, 29 October 2024
2024
2024The Impact of Diabetes Mellitus on Hematopoietic Stem Cell Mobilization
ÇELİK S., KAYNAR L., GÜVEN Z. T., KENİ BEGENDİ N., DEMİR F., KEKLİK M., et al.
20TH Annual Meeting of the Society of Hematologic Oncology (SOHO 2024), Texas, United States Of America, 4 - 07 September 2024, vol.24, pp.590
2024
2024Rare Anti-M Alloantibody Positivity in a Pregnant Woman and the Effectiveness of Plasmapheresis in Treatment: A Case Report
FİDAN K., BAYSAL S., KAYNAR L., AKYOL G., KEKLİK M., ÜNAL A.
20TH Annual Meeting of the Society of Hematologic Oncology (SOHO 2024), Texas, United States Of America, 4 - 07 September 2024, vol.24, pp.423
2023
2023Efficacy of therapeutic plasma exchange in patients with Crimean-Congo hemorrhagic fever
Beştepe Dursun Z., Korkmaz S., Türe Yüce Z., Kaynar L., Dursun A., Çelik İ.
16th World Intensive and Critical Care Congress (WICC), İstanbul, Turkey, 26 - 30 August 2023, vol.81, pp.85-87
2023
2023Hematopoietic Stem Cell Transplantation for Multiple Myeloma
KAYNAR L.
3rd Congress of Azerbaijan Hematology Specialists, Baku, Azerbaijan, 23 - 25 November 2023
2023
2023MULTIPLE MYELOM HASTALARININ MOBILIZASYONUNDA JENERİK PLERİXAFOR İLE ORİJİNAL PLERİXAFORUN ETKİNLİK VE GÜVENLİĞİNİN KARŞILAŞTIRILMASI: ÇOK MERKEZLİ ÇALIŞMA
YİĞİT KAYA S., MUTLU Y. G., YÜCEL O. K., ÖZEN İ. N., ATAŞ Ü., MELEK E., et al.
49. ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 05 November 2023
2023
2023KEMOTERAPİ ALMIŞ HEMATOLOJİK MALİGNİTELİ HASTALARDA CMV PCR TAKİBİ GEREKLİ MİDİR?
GÜVEN Z. T., DÜNDAR T., ÇELİK S., KEKLİK M., ÜNAL A., GÖKAHMETOĞLU S., et al.
49.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 05 November 2023
2023
2023SANTRAL SİNİR SİSTEMİ TUTULUMU (SSS) İLE SEYREDEN BİR MULTİPL MYELOM HASTASINDA ELRANATAMAB İLE ELDE EDİLEN YÜZ GÜLDÜRÜCÜ YANIT
MUTLU Y. G., YİĞİT KAYA S., MARAL S., MELEK E., BAŞLAR Z., KAYNAR L., et al.
49.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 05 November 2023
2023
2023ALLOJENİK KÖK HÜCRE NAKLİ SONRASINDA GELİŞEN SİTOMEGALOVİRÜS CİLT TUTULUMU: OLGU SUNUMU
ÖZALP Y. C., MARAL S., MELEK E., YİĞİT KAYA S., SEVİNDİK Ö. G., BEKÖZ H. S., et al.
49.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 05 November 2023
2023
2023AŞIRI TROMBOSİTOZLU HASTALARDA TERAPÖTİK TROMBOSİTAFEREZİN ETKİNLİĞİ VE GÜVENİLİRLİĞİ
ÇELİK S., GÜVEN Z. T., KEKLİK M., ÜNAL A., KAYNAR L.
49.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 05 November 2023
2023
2023YÜKSEK DOZ METOTREKSATIN BAŞARISIZ OLDUĞU SEKONDER SSS LENFOMA OLGUSUNDA TEDDI-R İLE TRANSPLANTASYONA BAŞARILI BİR KÖPRÜ TEDAVİ
YİĞİT KAYA S., MELEK E., MUTLU Y. G., BEKÖZ H. S., MARAL S., KAYNAR L., et al.
49.ULUSAL HEMATOLOJİ KONGRESİ, Antalya, Turkey, 1 - 05 November 2023
2023
2023AML'de DLI Uygulamaları
KAYNAR L.
18. ULUSAL AFEREZ KONGRESİ, Cyprus (Kktc), 20 - 21 October 2023
2023
2023OTOLOG HEMATOPOİETİK KÖK HÜCRE NAKLİ YAPILAN HASTALARDA SİTOMEGALOVİRÜS REAKTİVASYONUNUN DEĞERLENDİRİLMESİ
ERGİN M. I., KAYNAR L., ERGİN M., ÜNAL A.
10. Hematolojik Onkoloji Kongresi, Cyprus (Kktc), 28 - 30 September 2023
2023
2023ALL’de Allojeneik Kök Hücre Nakli
Kaynar L.
Akut Lösemi Çalıştayı, Sinop, Turkey, 16 September 2023
2023
2023The Tip of the Iceberg: Vaginal Bleeding and Granulocytic Sarcoma of the Uterus
ÇELİK S., GÜVEN Z. T., YILDIRIM T., KAYNAR L., ESER B., ÇETİN M., et al.
Society of Hematologic Oncology Eleventh Annual Meeting, United States Of America, 06 September 2023, pp.273
2023
2023THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DAEPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP
Vassilakopoulos T., FERHANOĞLU A. B., Horowitz N. A., Apostolidis J., Mellios Z., Piperidou A., et al.
28th Congress of the European Hematology Association, 8 - 15 June 2023, pp.2276-2277
2023
2023REAL‐LIFE EXPERIENCE WITH RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐da‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): A MULTINATIONAL ANALYSIS OF 274 PATIENTS
Vassilakopoulos T., FERHANOĞLU A. B., Horowitz N. A., Mellios Z., KAYNAR L., Zektser M., et al.
17th International Conference on Malignant Lymphoma, Switzerland, 13 - 17 June 2023, pp.410-411
2023
2023PLERIXAFOR IN AUTOLOGOUS STEM CELL TRANSPLANTATION: DOES IT AFFECT ENGRAFTMENT KINETICS?
SERİN İ., SEVİNDİK Ö. G., BALIK AYDIN B., MELEK E., MUTLU Y. G., BİLGEN H., et al.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Paris, France, 23 - 26 April 2023, pp.378-379
2023
2023EFFICACY COMPARISON OF LEVOFLOXACIN AND RIFAXIMIN PROPHYLAXIS IN PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
AKYOL G., PATAT Y., ÜNAL A., KEKLİK M., KAYNAR L.
49th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Paris, France, 23 - 26 April 2023, vol.58, pp.441-442
2023
2023DİYABETES MELLİTUS’UN HEMATOPOETİK KÖK HÜCRE MOBİLİZASYONUNA ETKİSİ
Çelik S., Güven Z. T., Keklik M., Ünal A., Kaynar L.
15.Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 16 - 19 March 2023
2023
2023MDS TANISI İLE HAPLOİDENTİK KÖK HÜCRE NAKLİ YAPILAN OLGUDA NADİR BİR ENFEKSİYON; HHV-6 ENSEFALİTİ
Melek E., Bayramova A., Aysan M., Yiğit Kaya S., Karaalioğlu B., Özden F., et al.
15.Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 16 March 2023
2023
2023KEMİK İLİĞİ NAKLİ YAPILAN HASTALARDA KARBAPENEME DİRENÇLİ ENTEROBACTERALES GELİŞİMİNİ ETKİLEYEN FAKTÖRLER
Şahin M., Sevil S., Beköz H. S., Kaynar L.
15.Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 16 - 19 March 2023
2023
2023TCRαβ DEPLESE HAPLOİDENTİK HKHN YAPILAN ÇOCUKLARDA AŞI ANTİKOR YANITLARI; TAM UYUMLU NAKİLLER İLE BENZER Mİ?
Kondolot M., Yılmaz E., Erdoğ Şahin N., Özcan A., Kaynar L., Ünal E., et al.
15.Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 16 - 19 March 2023
2023
2023KEMİK İLİĞİ NAKLİ YAPILAN HASTALARDA CLOSTRİDİUM DİFFİCLE ENFEKSİYONU
AŞKIN A. E., BEKTAŞ Ş., ŞAHİN M., SEVİL S., BEKÖZ H. S., KAYNAR L.
15.Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 16 - 19 March 2023
2023
2023ALLOGENEİK KÖK HÜCRE NAKLİ SONRASI GRAFT VERSUS HOST HASTALIĞI GELİŞEN HASTALARDA POSAKONAZOL TEDAVİ ETKİNLİĞİ
ÖKTEN A. A., KEKLİK M., KALIN ÜNÜVAR G., BAYDAR M., ÖKTEM F., AKYOL G., et al.
15.Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 16 - 19 March 2023
2023
2023YÜKSEK DOZ MELFALAN REJİMİNİN TEK GÜN İLE EŞİT İKİ GÜNLÜK BÖLÜNMÜŞ DOZLARDA UYGULANMASININ KARŞILAŞTIRILMASI
KARAKUŞ V., MARAL S., YÜCEL O. K., YİĞİT KAYA S., VURAL E., ÇERÇİ K., et al.
15.Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 16 March 2023
2023
2023KEMİ İLİĞİ NAKLİ YAPILAN HASTALARDA KARBAPENEME DİRENÇLİ ENTEROBACTERALES GELİŞİMİNİ ETKİLEYEN FAKTÖRLER
ŞAHİN M., SEVİL S., BEKÖZ H. S., KAYNAR L.
15. ULUSAL KEMİKİLİĞİ TRANSPLANTASYONU VE HÜCRESEL TEDAVİLER KONGRESİ, Antalya, Turkey, 16 - 19 March 2023
2022
2022Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: Incidence and Risk Factors in the Rituximab Era
Vassilakopoulos T., Panitsas F., Mellios Z., Apostolidis J., Piperidou A., Michael M., et al.
64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), United States Of America, 10 December 2022, vol.140, pp.9554-9556
2022
2022Comparison of Efficacy and Safety of Generic Plerixafor Vs Original Plerixafor in the Mobilization of Myeloma Patients
SEVİNDİK Ö. G., BİLGEN H., SERİN İ., MELEK E., KARAKUŞ V., ÇERÇİ K., et al.
64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), United States Of America, 10 December 2022, vol.140, pp.12803-12804
2022
2022EVALUATION OF COVID-19 FEAR AND QUALITY OF LIFE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION DURING THE COVID-19 PANDEMIC
ÇELİK S., GÜVEN Z. T., İPEKTEN F., KEKLİK M., ÜNAL A., KAYNAR L.
XIII Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 5 - 08 October 2022, vol.44, pp.16
2022
2022EVALUATION OF REFEEDING HYPOPHOSPHATEMIA FREQUENCY, RISK FACTORS AND NUTRITIONAL STATUS DURING STEM CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGIC MALIGNANCY
Ergül Ş., Güneş Şahin G., Özer N. T., Kaynar L., Çelik S., Gündoğan K.
44TH ESPEN Congress 2022, Vienna, Austria, 3 - 06 September 2022
2022
2022Post-authorization safety of lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma in Turkey
Tuğlular A. T., Pehlivan M., Sönmez M., Hacıoğlu S., Saydam G., Ayyıldız M. O., et al.
19th International Myeloma Society Annual Meeting, California, United States Of America, 25 - 27 August 2022, pp.190-191
2022
2022RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES
Vassilakopoulos T., FERHANOĞLU A. B., Horowitz N. A., Apostolidis J., Mellios Z., KAYNAR L., et al.
27th Congress of the European Hematology Association, Austria, 15 August 2022, pp.1114-1115
2022
2022P1227 POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD DATA FROM TURKEY
DAL M. S., UNCU ULU B., UZAY A., AKAY O. M., BEŞIŞIK S., YENEREL M. N., et al.
EHA2022 Hybrid Congress, VİYANA, Austria, 9 - 17 June 2022, pp.2146-2148
2021
2021HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study
ÖZBALAK M. M., AKAY O. M., PEHLİVAN M., YILDIZ B., UZAY A., YİĞENOĞLU T. N., et al.
Society of Hematologic Oncology Ninth Annual Meeting(SOHO 2021), United States Of America, 8 - 11 September 2021, vol.21, pp.368-369
2021
2021RITUXIMAB‐DOSE‐ADJUSTED EPOCH (R‐DA‐EPOCH) IN PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (PMLBCL): REAL‐LIFE EXPERIENCE ON 190 PATIENTS FROM 3 MEDITERRANEAN COUNTRIES
Vassilakopoulos T., FERHANOĞLU A. B., Horowitz N. A., Mellios Z., KAYNAR L., Zektser M., et al.
16th International Conference on Malignant Lymphoma, Virtual Edition, Switzerland, 18 June 2021
2020
2020Relaps Diffüz Büyük B Hücreli Lenfoma Tanılı Hastalarda Polatuzumab Vedotin Deneyimi: üç olgu sunumu
GÜVEN Z. T., KAYNAR L., ÜNAL A.
7. Hematolojik Onkoloji Kongresi, Turkey, 11 - 13 December 2020, pp.16-17
2020
2020APLASTİK ANEMİ İLE BİRLİKTELİĞİ OLAN VE OLMAYAN PNHHASTALARINDA ALLOJENEİK KÖK HÜCRE NAKLİ DENEYİMİ
YILMAZ A. F., SOYER N., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., TOPÇUOĞLU P., ÜNAL A., et al.
46. Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, pp.86
2020
2020HEMATOLOJİK HASTALIKLARDA COVID-19 SIKLIĞI VE SEYRİÇOK MERKEZLİ KAYIT ÇALIŞMASI
KAYNAR L.
46.Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, pp.79-80
2020
2020AKUT PROMİYELOSİTİK LÖSEMİ HASTALARINDA ATRAVE ARSENİK İLE ATRA VE İDARUBİSİN TEDAVİLERİNİNKARŞILAŞTIRILMASI
ÇELİK S., ÜNAL A., ŞAHİN R., GÜVEN Z. T., BAYDAR M., KEKLİK M., et al.
46.Ulusal Hematoloji Kongresi, Turkey, 28 - 31 October 2020, pp.86-87
2020
2020Caplacizumab induces fast and durable platelet count responses with improved time to complete remission and recurrence-free survival in patients with acquired thrombotic thrombocytopenic purpura
Kaynar L., Coppo P., Scully M., Larubia J., Peyvandi F., Cataland S., et al.
XIth Eurasian Hematology Oncology, 21 - 24 October 2020, vol.42, pp.62-63
2020
2020A New Hope in the Treatment of steroid-refractory Graft Versus Host Disease (Sr-GVHD) after Allogeneic Hematopoetic Stem Cell Transplantation (AHSCT): Ruxolitinib
İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., DEVECİ B., PEHLİVAN M., KAYNAR L., et al.
The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation, 29 August - 01 September 2020, vol.55, pp.329-330
2020
2020GASTROINTESTINAL PLASMOBLASTIC LYMPHOMAASSOCIATED WITH WISKOTT-ALDRICH SYNDROME: A CASEREPORT
ÜNAL A., ÇELİK S., GÜVEN Z. T., KAYNAR L., ESER B., KONTAŞ O., et al.
25th Congress of the European Hematology Association Virtual Congress, 11 - 22 June 2020, pp.1014
2020
2020SECONDARY HYPOGAMMAGLOBULINEMIA INPATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIARECEIVING IBRUTINIB THERAPY
ÇELİK S., GÜVEN Z. T., ÜNAL A., KAYNAR L.
25th Congress of theEuropean HematologyAssociation, 11 - 22 June 2020, pp.874
2020
2020BRENTUXIMAB VEDOTIN CONSOLIDATION THERAPY AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK HODGKIN’xxS LYMPHOMA: MULTI-CENTER REAL-LIFE EXPERIENCE
FERHANOĞLU A. B., ALTUNTAŞ F., ÖZBALAK M. M., Yıldız B., Yiğenoğlu T. N., YÖNAL HİNDİLERDEN İ., et al.
European Hematology Association 2020 Virtual Congress, Frankfurt, Germany, 11 - 21 June 2020
2020
2020EVALUATION OF PATIENTS WITH ADULT ONSETLANGERHANS CELL HISTIOCYTOSIS: A SINGLE CENTEREXPERIENCE
ÜNAL A., ÇELİK S., GÜVEN Z. T., AŞIK O., KAYNAR L., ESER B., et al.
25th Congress of theEuropean Hematology Association Virtual Congress, 11 - 22 June 2020, pp.992
2020
2020OKHN UYGULANMIŞ YÜKSEK RİSKLİ HL’DE BRENTUKSİMABVEDOTİN KONSOLİDASYONU GERÇEK YAŞAM VERİLERİ:ÇOK MERKEZLİ ÇALIŞMA
AKAY O. M., ÖZBALAK M. M., YILDIZ B., PEHLİVAN M., YİĞENOĞLU T., UZAY A., et al.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 5 - 07 March 2020, pp.46
2020
2020NAKİL HASTALARINDA GRANÜLOSİT SÜSPANSİYONUKULLANIMININ ENGRAFTMAN SÜRECİNE ETKİSİ
YILMAZ E., ÖZCAN A., KAYNAR L., ÜNAL E., PATIROĞLU T., KARAKÜKCÜ M.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 5 - 07 March 2020, pp.71
2020
2020ALLOJENEİK KÖK HÜCRE NAKLİ SONRASI NADİR BİRKOMPLİKASYON: ASPERGİLLUS OSTEOMİYELİTİ
ÇELİK S., CİVAN M., GÜVEN Z. T., KAYNAR L.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 5 - 07 March 2020, pp.95
2020
2020AKUT LÖSEMİDE İN VİTRO T HÜCRE DEPLESYONU VE NAKİL SONRASI SİKLOFOSFAMİDLE YAPILAN HAPLOİDENTİKNAKİL SONUÇLARIMIZ
GÜVEN Z. T., KAYNAR L., ÇELİK S., KEKLİK M., ÜNAL A., ÇETİN M.
12. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 5 - 07 March 2020, pp.61-62
2019
2019Turkish Acute Lymphoblastic Leukemia Registry, Retrospective Phase Data
DEMİRKAN F., CİFTCİLER R., SEVİNDİK Ö. G., ERKURT M. A., VURAL F., TURGUT B., et al.
American Society of Hematology, 7 - 10 December 2019
2019
2019CYP450 polimorfizmlerinin vorikonazol kan düzeyi ve doza bağlı istenmeyen etkilerle ilişkisi
DEMİRPOLAT E., AYCAN M. B., METAN G., KAYNAR L., ÇETİN M.
25. Ulusal Farmakoloji Kongresi, Antalya, Turkey, 4 - 07 November 2019, pp.132
2019
2019RELAPS VE REFRAKTER HODGKİN LENFOMADA BRENTUXİMAB VEDOTİN UZUN DÖNEM SONUÇLARI: ÇOKMERKEZLİ GERÇEK YAŞAM DENEYİMİ
ÖZBALAK M. M., SALİHOĞLU A., SOYSAL T., karadoğan i., PAYDAŞ S., ÖZDEMİR E., et al.
45. Ulusal Hematoloji Kongresi, Antalya, Turkey, 30 October - 02 November 2019, pp.159-160
2019
2019Relaps/Refrakter Hodgkin Lenfomada Nivolumab: Çok Merkezli Türkiye Deneyimi Uzun Dönem Sonuçları
BEKÖZ H. S., ÖZBALAK M. M., KARADURMUŞ N., PAYDAŞ S., TÜRKER F. A., TOPTAŞ T., et al.
45. Ulusal Hematoloji Kongresi, Antalya, Turkey, 30 October - 02 November 2019
2019
2019HEMATOPOETİK KÖK HÜCRE NAKLİ SONRASITROMBOSİTOPENİ TEDAVİSİNDE ELTROMBOPAGKULLANIMI TEK MERKEZ DENEYİMİ
GÜVEN Z. T., ÇELİK S., KAYNAR L., ÇETİN M., ÜNAL A.
45. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 31 October - 02 November 2019
2019
2019KRONİK LENFOSİTİK LÖSEMİ’NİN NADİR BİR PREZENTASYONU POSTRENAL AKUT BÖBREK YETMEZLİĞİ:OLGU SUNUMU
ÇELİK S., GÜVEN Z. T., ESER B., KAYNAR L., ÇETİN M., ÜNAL A.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.252
2019
2019GVHD’DE NR3C1 GENİ PROMOTOR METİLASYONU VE GLUKOKORTİKOİD RESEPTÖR DİRENCİ ARASINDAKİ İLİŞKİNİN ARAŞTIRILMASI
Hutanu E. D., GÖKÇE N., TAHERİ S., ERMİŞ TURAK E., KARAKÜKCÜ M., KAYNAR L., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October 2019, pp.115
2019
2019ÇOK NADİR GÖRÜLEN BİR HEMOGLOBİNOPATİ OLGUSU:HBS-BETA TALASEMİ HASTALIĞI
KARACA E., GÜVEN Z. T., KAYNAR L., ÇETİN M., ÜNAL A., ESER B.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.346
2019
2019AKUT LÖSEMİ TANILI HASTALARDA İKİNCİ ALLOJENİK HEMATOPOETİK KÖK HÜCRE NAKLİ DENEYİMLERİMİZ
GÜVEN Z. T., ÇELİK S., KAYNAR L., ESER B., ÇETİN M., ÜNAL A.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.151-152
2019
2019KÖK HÜCRE NAKLİNDE; NÖTROPENİK ATEŞLİ HASTALARDA GRANÜLOSİT TRANSFÜZYONUNUN ENGRAFMAN ÜZERİNE ETKİSİ
İTMEÇ Y., GÜVEN Z. T., ÇELİK S., KAYNAR L., ESER B., ÇETİN M., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.144
2019
2019ALLOJENİK KÖK HÜCRE NAKLİ UYGULANAN HASTALARDA ANTİFUNGAL İLAÇLARIN SİKLOSPORİN KAN SEVİYESİNE ETKİLERİNİN ARAŞTIRILMASI
GÜNAY A., GÜVEN Z. T., ÇELİK S., DEMİRPOLAT E., AYCAN M. B., KAYNAR L., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.234-235
2019
2019TTP İLE BAŞVURAN YAYGIN KEMİK İLİĞİ METASTAZLI MİDE ADENOKARSİNOMA OLGUSU
ÇELİK A., ÇELİK S., GÜVEN Z. T., KAYNAR L., ESER B., ÇETİN M., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.278
2019
2019RELAPS REFRAKTER SOĞUK AGLÜTİNİN HASTALIĞI OLAN VAKADA BORTEZOMİB İLE ETKİLİ VE BAŞARILI TEDAVİ
ÇELİK S., GÜVEN Z. T., ESER B., KAYNAR L., ÇETİN M., ÜNAL A.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.345
2019
2019AKUT MYELOİD LÖSEMİ TANILI HASTADA SİTOZİN ARABİNOZİD+İDARUBUSİN SONRASINDA GÖRÜLEN TAKOTSUBO KARDİYOMİYOPATİSİ
EMİROĞLU E., GÜVEN Z. T., ÇELİK S., ESER B., KAYNAR L., ÇETİN M., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.279
2019
2019IMID/PI İÇEREN TEDAVİLERE DİRENÇLİ MM OLGULARINDA POM/LEN İLE BİRLİKTE ELOTUZUMAB TEDAVİSİ KALICI ≥ÇİKY SAĞLAYABİLİR Mİ?
BEKSAÇ M., CENGİZ SEVAL G., PAYDAŞ S., TUĞLULAR A. T., ARSLAN Ö., GÖKER H., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.168
2019
2019İBRUTİNİB TEDAVİSİ ALAN HEMATOLOJİK MALİGNİTELİ HASTALARDA SEKONDER HİPOGAMAGLOBULİNEMİNİN DEĞERLENDİRİLMESİ
ÇELİK S., GÜVEN Z. T., KAYNAR L., ESER B., ÇETİN M., ÜNAL A.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.165
2019
2019KRONİK LENFOSİTER LÖSEMİ: PROSPEKTİF TÜRKİYE KAYIT ÇALIŞMASI
TURGUT B., BOĞA C., AKTAN M., SEVİNDİK Ö. G., PAYZIN K. B., KAYNAR L., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.174
2019
2019İLERİ YAŞLI HASTADA NADİR BİR SOĞUK AGLUTİNİN HASTALIĞI SEBEBİ: SJÖGREN SENDROMU
ÇELİK S., GÜVEN Z. T., ESER B., KAYNAR L., ÇETİN M., ÜNAL A.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.342
2019
2019WİSKOTT- ALDRİCH SENDROMU ZEMİNİNDE GELİŞEN GASTROİNTESTİNAL PLAZMOBLASTİK LENFOMA: OLGU SUNUMU
ÜNAL A., ÇELİK S., GÜVEN Z. T., KAYNAR L., ESER B., ÇETİN M.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.262
2019
2019BÜYÜK PROBLEM AHKHN SONRASINDA GELİŞEN GVHH TEDAVİSİNDE YENİ BİR UMUT: JANUS KİNAZ 1/2 İNHİBİTÖRÜ
İLHAN O., CENGİZ SEVAL G., CİVRİZ BOZDAĞ S., DEVECİ B., PEHLİVAN M., KAYNAR L., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.114
2019
2019İZOLE KUTANÖZ ROSAİ-DORFMAN-DESTOMBES HASTALIĞI: OLGU SUNUMU
ÇELİK S., GÜVEN Z. T., ESER B., KAYNAR L., ÇETİN M., ÜNAL A.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, pp.257
2019
2019Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy
ÇELİK S., GÜVEN Z. T., KAYNAR L., ESER B., ÇETİN M., ÜNAL A.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, pp.21
2019
2019Risk factors for invasive fungal infection in patients who underwent allogeneic hematopoietic stem cell transplantation
yıldızhan e., varal f., ÇİFTÇİ S., COŞKUN E., YILDIZ G., YANAR A., et al.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, pp.60
2019
2019Successful treatment of relapsed and refractory cold agglutinin disease with bortezomib: case report
ÇELİK S., GÜVEN Z. T., ESER B., KAYNAR L., ÇETİN M., ÜNAL A.
10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85, pp.68-69
2019
2019Single Center Experience: Retrospective Evaluation of Patientswith Primary Mediastinal Large B-Cell Lymphoma
GÜVEN Z. T., ÇELİK S., KAYNAR L., ÇETİN M., ÜNAL A.
AHOS 2019, Turkey, 3 - 06 October 2019
2019
2019RITUXIMAB-DOSE-ADJUSTED-EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): THE COMBINED GREEK AND TURKISH REALLIFE EXPERIENCE ON OUTCOMES AND PROGNOSTIC FACTORS
Vassilakopoulos T., Mellios Z., KAYNAR L., Verigou E., Papageorgiou S., Giatra H., et al.
6TH AEGEAN HEMATOLOGY ONCOLOGY SYMPOSIUM, Turkey, 3 - 06 October 2019, pp.34-35
2019
2019INVESTIGATION OF THE EFFECTS OF ANTIFUNGAL DRUGS ON CYCLOSPORIN BLOOD LEVEL IN PATIENTS WITH ALLOGENEIC STEM CELL TRANSPLANTATION: SINGLE CENTER EXPERIENCE
GÜNAY A., GÜVEN Z. T., ÇELİK S., DEMİRPOLAT E., MÜKERREM B. A., KAYNAR L., et al.
6th AEGEAN HEMATOLOGY ONCOLOGY SYMPOSIUM, İzmir, Turkey, 3 - 06 October 2019
2019
2019Long-term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-center Real-life Experience
FERHANOĞLU A. B., ÖZBALAK M. M., Salihoğlu A., SOYSAL T., Karadogan İ., PAYDAŞ S., et al.
6th Aegean Hematology Oncology Symposium, 3 - 06 October 2019
2019
2019A VERY RARE CASE OF HEMOGLOBINOPATHY: HBS-BETA THALASSEMIA DISEASE
KARACA E., ÇELİK S., GÜVEN Z. T., KAYNAR L., ÇETİN M., ÜNAL A., et al.
6TH AEGEAN HEMATOLOGY ONCOLOGY SYMPOSIUM, İzmir, Turkey, 3 - 06 October 2019, pp.121
2019
2019Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable = Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey
BEKSAÇ M., CENGİZ SEVAL G., PAYDAŞ S., TUĞLULAR A. T., ARSLAN Ö., GÖKER H., et al.
17th International Myeloma Workshop, Boston, United States Of America, 12 - 15 September 2019, vol.19, pp.242-243
2019
2019NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI-CENTER EXPERIENCE IN TURKEY
FERHANOĞLU A. B., ÖZBALAK M. M., BEKÖZ H. S., KARADURMUŞ N., PAYDAŞ S., TÜRKER F. A., et al.
24th European Hematology Association, Amsterdam, Netherlands, 13 - 16 June 2019, vol.3, pp.567-568
2019
2019Can long non-coding RNA HOTAIR be a novel biomarker in the diagnosis of CML
BENTLİ E., AKBAROVA Y., AKALIN H., TAŞCIOĞLU N., SARAYMEN B., ÇETİN M., et al.
VI.Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Turkey, 19 - 21 April 2019
2019
2019Allojenik Kemik İliği Transplantasyonu Sonrası GelişenToksoplazma Ensefaliti Olgusu
ULU KILIÇ A., KALIN ÜNÜVAR G., KAYNAR L., MUMCU N.
7. TÜRKİYE EKMUD BİLİMSEL PLATFORMU “ULUSLARARASI KONGRE” 3-7 NİSAN 2019, 3 - 07 April 2019
2019
2019Successful haploidentic bone marrow transplantation with inotuzumab ozogamicin in patient with relapsed and resistant B cell acute lymphoblastic leukemia
ÜNAL A., ÇELİK S., GÜVEN Z. T., ESER B., KAYNAR L., ÇETİN M.
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Frankfurt, Germany, 24 - 27 March 2019, vol.54, pp.523-524
2019
2019THE RELATIONSHIP BETWEEN VORICONAZOLE SIDE EFFECTS, PLASMA CONCENTRATION AND POLYMORPHISMS IN HEMATOLOGICAL MALIGNANCY PATIENTS
DEMİRPOLAT E., AYCAN M. B., METAN G., KAYNAR L., ÇETİN M.
EUFEPS Annual Meeting 2019, Frankfurt, Germany, 6 - 08 March 2019
2019
2019HODGKİN HASTALIĞINDA OTOLOG PKHN İÇİN KULLANILAN BEAM VE MİTOXANTRON/ MELFALAN HAZIRLAMA REJİMLERİNİN KARŞILAŞTIRILMASI
YERAL M., aytan p., güngör b., BOĞA C., ÜNAL A., koç y., et al.
11. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 03 March 2019
2019
2019Screening molecular markers in various hematological malignancies
AKYÜREK E., TAŞÇIOĞLU N., AKALIN H., SAATÇİ Ç., ÖZKUL Y., ÖZCAN A., et al.
International Participated Erciyes Medical Genetics Days 2019, Turkey, 21 February 2019
2019
2019Investigation of hematological malignancies with cytogenetic and fluorescent in situ hybridization methods
Mermer D. B., AKALIN H., GÖKÇE N., BAŞGÖZ N., KAYNAR L., SAATÇİ Ç., et al.
International Participated Erciyes Medical Genetics Days 2019, Kayseri, Turkey, 21 - 23 February 2019
2018
2018İMMÜN YETMEZLİKLİ HASTALARDAN ELDE EDİLEN SİTOMEGALOVİRÜS (CMV) SUŞLARININ GENOTİPLERİNİN BELİRLENMESİ VE GANSİKLOVİR DİRENCİNİN ARAŞTIRILMASI
coşkun a., GÖKAHMETOĞLU S., MİDİLLİ K., KARAKÜKCÜ M., KAYNAR L., KUŞKUCU M. A., et al.
XXXVIII. Uluslararası Türk Mikrobiyoloji Kongresi, Antalya, Turkey, 4 - 08 November 2018, pp.243
2018
2018Kök Hücre Nakli Sonrası İdame Tedavileri
KAYNAR L.
44. Ulusal Hematoloji Kongresi, Antalya, Turkey, 31 October - 03 November 2018
2018
2018The comparison of melphalan administration on day-3 with administration on day-1 on neutrophil and platelet engraftment in multiple myeloma patients undergoing autologous stem cell transplantation
ÜNAL A., KAYNAR L., KENİ N., ESER B., ÇETİN M.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, pp.43-44
2018
2018Autologous stem cell transplantation and CMV
Ergin m., Ergin m. ı., KAYNAR L.
LEUKEMIA RESEARCH, İstanbul, Turkey, 17 - 20 October 2018, vol.73, pp.41-42
2018
2018Successful Treatment With Granulocyte Transfusion and Early Neutrophil Engraftment in Allogeneic Transplant Patients With Febrile Neutropenia: Does Granulocyte Transfusion Effect on Neutrophil Engraftment?
ÜNAL A., birekul a., KAYNAR L., ESER B., ÇETİN M.
2018 World Cancer Congress, Malaysia, 28 - 30 September 2018
2018
2018The Comparison of Melphalan Administration on Day −3 With Administration on Day −1 on Neutrophil and Platelet Engraftment in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
ÜNAL A., KAYNAR L., KENİ BEGENDİ N., ESER B., ÇETİN M., YILDIZHAN E., et al.
2018 World Cancer Congress, Malaysia, 28 September 2018
2018
2018Posaconazole prophylaxis in patients with acute myeloid leukemia: A real life experience from a prospective multicenter observational study
METAN G., ETGÜL S., çiftçioğlu a., saba r., ULU KILIÇ A., YILMAZ H., et al.
20th International Society for Human and Animal Mycology, Netherlands, 30 June - 04 July 2018, vol.56, pp.1-159
2018
2018Hematolojik Malignitesi Olan Hastalarda Gelişen Pnömoniiçin Risk Faktörleri ve Mortalite Oranları
ALP MEŞE E., ULU KILIÇ A., eren e., KAYNAR L., CEVAHİR F.
EKMUD, 8 - 13 May 2018
2018
2018Allojenik kök hücre nakil alıcılarında invaziv fungal enfeksiyon insidansı ve risk faktörlerinin değerlendirilmesi
YAQOBOVA L., CEVAHİR F., ULU KILIÇ A., ALP E., KAYNAR L., ESER B., et al.
3. Ulusal Kan ve Kemik İliği Nakli Kongresi, Girne, Cyprus (Kktc), 29 - 31 March 2018
2018
2018TESTİKÜLER GERM HÜCRELİ TÜMÖRLERDE OKİT ÖNCESİ NÖTROFİL LENFOSİT ORANININ PROGRESYONSUZ SAĞ KALIMA ETKİSİ
DERİN S., İNANÇ M., KAYNAR L., BOZKURT O., ŞAKALAR T., DOĞAN E., et al.
7 . Türk Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2018
2018
2018Akut Lösemilerde 9/10 Akrabadışı Verici Yerine Haploidentik Verici Kullanılabilir mi? - Erişkin Gözü ile
KAYNAR L.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Turkey, 1 - 03 March 2018
2018
2018OTOLOG KÖK HÜCRE NAKLİ SONRASI REZİDÜ HASTALIĞIOLAN MULTİPL MİYELOM HASTALARINDA LENALİDOMİDİNSAĞKALIM ÜZERİNE ETKİSİ
ÜNAL A., GÜVEN Z. T., KAYNAR L., yıldızhan e., KENİ N., MANDACI ŞANLI N., et al.
10. Ulusal Kemik İliği Transplantasyonu ve Hücresel Tedaviler Kongresi, Antalya, Turkey, 1 - 03 March 2018, pp.111-112
2017
2017Long-Term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-Center Real-Life Experience
Ferhanoğlu A. B., Özbalak M. M., Salihoğlu A., Soysal T., Karadoğan I., Paydaş S., et al.
2017 ASH, California, United States Of America, 08 December 2017
2017
2017Effect of Different Treatment Patterns to Cost Effectiveness in Chronic Lymphocytic Leukemia Patients, Turkish CLL Study Group
DEMİRKAN F., VURAL F., TEKİNALP A., SEVİNDİK Ö. G., SAYINALP N., KAYNAR L., et al.
59. American Society of Hematology Annual Meeting, ATLANTA, United States Of America, 7 - 11 December 2017, vol.130, pp.5348
2017
2017İmmun yetmezlikli hastalardan elde edilen sitomegalovirus (CMV) suşlarının genotiplerinin belirlenmesi
coşkun a., GÖKAHMETOĞLU S., KAYNAR L., KARAKÜKCÜ M., ÇETİN M.
4.ulusal klinik mikrobiyoloji kongresi, Turkey, 8 - 12 November 2017
2017
2017Akut Lenfoblastik Lösemi, Türkiye Kayıt Çalışması
SEVİNDİK Ö. G., BÜYÜKAŞIK Y., TEKGÜNDÜZ E., ERKURT M. A., VURAL F., TURGUT B., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017
2017
2017YÜKSEK FİBRİNOJEN DÜZEYİ İLE ARTMIŞ KRONİK GRAFT VERSUS HOST HASTALIĞI (KGVHH) RİSKİ ARASINDAKİ KUVVETLİ İLİŞKİ
MANDACI ŞANLI N., KAYNAR L., ESER B., ÇETİN M., ÜNAL A.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, pp.36
2017
2017Nüks veya Refrakter Hodgkin Lenfoma Hastalarında Nivolumab Kullanımı Türkiye Verileri
FERHANOĞLU B., BEKÖZ H. S., KARADURMUŞ N., PAYDAŞ S., TÜRKER A., TOPTAŞ T., et al.
43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017
2017
2017DAHA ÖNCE YOĞUN TEDAVİ ALMIŞ RELAPS/REFRAKTERMULTİPL MİYELOM HASTALARINDA DARATUMUMABINETKİLİLİK VE GÜVENLİLİĞİ
BEKSAÇ M., aydın y., GÖKER H., TURGUT M., kalayoğlu beşışık s., çağırgan s., et al.
43. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 1 - 04 November 2017
2017
2017Successful Treatment with Granulocyte Transfusion and Early Neutrophil Engraftment in Allogeneic Transplant Patients with Febrile Neutropenia
ÜNAL A., birekul a., KAYNAR L., KENİ N., ESER B., KÖKER M. Y., et al.
The 22nd InternationalCongress of Asia-Pacific Bloodand Marrow TransplantationThe 4th International and 7th National Congress on Stem Cells and the 2nd Annual Nursing Congress on Hematopoietic Stem Cell Transplantation, Iran, 28 - 30 October 2017, pp.83
2017
2017AML ‘ de Nüksün Önlenmesinde DLI Uygulamaları:Proflaktik? Preemptif?
KAYNAR L.
12. Ulusal Aferez Kongresi, Turkey, 26 - 29 October 2017
2017
2017COMPARISON OF HYPOMETHYLATING AGENTS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROME: RETROSPECTIVE ANALYSIS, SINGLE CENTER EXPERIENCE
ÜNAL A., KENİ N., yıldızhan e., ERMİŞ TURAK E., KAYNAR L., ZARARSIZ G., et al.
VIII. International Eurasian Hematology-Oncology Congress, İstanbul, Turkey, 18 - 21 October 2017, vol.61, pp.22
2017
2017Therapeutic drug monitorization for voriconazole: Experience from Turkey
METAN G., Kahraman v., KAYNAR L., Karakürkçü m., Demir K., Akfırat s., et al.
8th Trends in Medical Mycology, Belgrade, Serbia, 6 - 09 October 2017, pp.221
2017
2017Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey
FERHANOĞLU A. B., BEKÖZ H. S., KARADURMUŞ N., PAYDAŞ S., GÜLBAŞ Z., TÜRKER F. A., et al.
The 22nd European Hematology Congress, Madrid, Spain, 22 - 25 June 2017, vol.102, pp.84
2017
2017Nivolumab for Relapsed or refractory Hodgkin Lymphoma: Exprience in Turkey
FERHANOĞLU A. B., BEKÖZ H. S., KARADURMUŞ N., PAYDAŞ S., GÜLBAŞ Z., TÜRKER A., et al.
22nd Congress of the European Hematolgy Association, 22 - 25 June 2017
2017
2017URIC ACID LEVEL MIGHT BE A PROGNOSTIC INDICATOR FOR SURVIVAL IN PATIENTS WHO UNDERWENT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION. SINGLE CENTER EXPERIENCE
MANDACI ŞANLI N., ŞIVGIN S., KAYNAR L., ESER B., ÇETİN M., ÜNAL A.
22nd Congress ofthe European Hematology Association, Madrid, Spain, 22 - 25 June 2017, vol.102, pp.859
2017
2017EFFECT OF DIFFERENT TREATMENT PATTERNS TO COST EFFECTIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
DEMİRKAN F., VURAL F., tekinalp a., SEVİNDİK Ö. G., SAYINALP N., KAYNAR L., et al.
6th International Congress on Leukemia Lymphoma Myeloma, 11 - 13 May 2017, pp.143-144
2017
2017Alpha/Beta T cell depleted Donor Lymphocyte Infusion
KAYNAR L., KARAKÜKCÜ M., ÜNAL E., ÖZCAN S., TEZCAN KARASU G., ACAR M. B.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 March 2017, pp.86
2017
2017Successful treatment with granulocyte transfusion and early neutrophil engraftment in allogeneic transplant patients with febril neutropenia do granulocyte transfusions help and accelerate neutrophil engraftment?
ÜNAL A., KAYNAR L., KENİ N., birekul a., yıldızhan e., ŞIVGIN S., et al.
43rd Annual Meeting of the European Society for Blood and Marrow Transplantation, 26 - 29 March 2017, pp.124
2016
2016A Multicenter Experience of Thrombotic Microangiopathies in Turkey The Turkish Hematology Research and Education Group ThREG TMA01 Study
TEKGÜNDÜZ E., YILMAZ M., ERKURT M. A., KİKİ İ., KAYA A. H., KAYNAR L., et al.
58th ASH Annual Meeting, 3 - 06 December 2016
2016
2016A nation wide survey of patients with homozygous familial hypercholesterolemia undergoing lipoprotein apheresis in Turkey A HIT Registry
KAYIKÇIOĞLU L. M., TOKGÖZOĞLU S. L., PIRILDAR Ş., YILMAZ M., KAYNAR L., AKTAN M., et al.
32. Uluslararası Katılımlı Türk Kardiyoloji Kongresi, Turkey, 20 - 23 October 2016, vol.37, pp.1-189
2016
2016Unisentrik Castleman Hastalığına sekonder gelişen amiloidoz ve son dönem böbrek yetmezliği
EROĞLU E., KOÇYİĞİT İ., ÜNAL A., SİPAHİOĞLU M. H., AKGÜN H., KAYNAR L., et al.
33. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Turkey, 19 - 23 October 2016
2016
20165 year Experience of Oral Deferasirox Exjade Use Prior to Transplantation in Patients with Iron Overload that Underwent Allogeneic Hematopoietic Stem Cell Transplantation alloHSCT Retrospective Analysis of a Single Center from Turkey
ŞIVGIN S., YILDIZHAN E., MANDACI ŞANLI N., KAYNAR L., ZARARSIZ G., ESER B., et al.
The fourth annual meeting of the Society of Hematologic Oncology (SOHO 2016), 7 - 10 September 2016
2016
2016Serum Ferritin Levels Prior to Transplantation Might be Used for Predicting the Severity of Transfusional Iron Overload in Allogeneic Hematopoietic Stem Cell Transplantation alloHSCT Recipients
ŞIVGIN S., KARAKUŞ E., YILDIZHAN E., ZARARSIZ G., KAYNAR L., ESER B., et al.
The fourth annual meeting of the Society of Hematologic Oncology (SOHO 2016), 7 - 10 September 2016, vol.16, pp.28-29
2016
2016Clinical management and quality of life ın patients with homozygous familial hypercholesterolemia undergoing lipid apheresis in Turkey first results of a nation wide survey A HIT registry
KAYIKÇIOĞLU L. M., TOKGÖZOĞLU S. L., PARILDAR M., YILMAZ M., KAYNAR L., AKTAN M., et al.
84th Congress of the European-Atherosclerosis-Society (EAS), 29 May - 01 June 2016
2016
2016HLA- A,−B AND -DRB1 ALLELE FREQUENCIES INALLOGENEIC AND HAPLOIDENTICALHEMATOPOIETIC STEM CELL TRANSPLANTATIONAND THEIR RELATIONSHIPS TO MORTALITY
PATIROĞLU T., AKAR H. H., ÇETİN M., KAYNAR L., ÜNAL A.
30th European Immunogenetics and Histocompatibility Conference, Greece, 11 - 14 May 2016, vol.87, pp.263
2016
2016Pneumomediastinum Case Secondary to Pneumocystis Jirovecii Infection as Late Complication in an Allogeneic Hematopoietic Stem Cell Tranplant Patient
Akyol G., Ermiş Turak E., Yıldızhan E., Demir K., Çetin M., Kaynar L.
42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, Valencia, Spain, 3 - 06 April 2016, vol.51, pp.566
2016
2016Plerixafor use in prevention of mobilization failure of autologous stem cell A single center experience
Birekul A., Ünal A., Ünal M. Ç., Kaynar L., Baktır M. A., Ermiş Turak E., et al.
42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, Valencia, Spain, 3 - 06 April 2016, vol.51, pp.136-137
2015
2015The Comparison of the Autologous Peripheral Blood Stem Cell Mobilization and Collection in Young and Elderly Patients
birekul a., ÜNAL A., ÜNAL M. Ç., YILDIZHAN E., ŞIVGIN S., ERMİŞ TURAK E., et al.
ASH 2015, United States Of America, 3 - 05 December 2015
2015
2015Konu Türk Aferez Derneği Bursu
KAYNAR L.
10.Ulusal Aferez Kongresi, Turkey, 5 - 08 November 2015
2015
2015HKH Nakli Amacıyla Hangi Tip Kök Hücreler Kullanılabilir Mobilizasyon Ne Demektir Kök Hücreleri Hasta veya Donörden Toplamak İçin Hangi Yollar İzlenir
KAYNAR L.
VI. Uluslararası Avrasya Hematoloji Kongresi, 14 - 17 October 2015
2015
2015Is Piperacilline Tazobactam Effective as Carbapenem in Empirical Antimicrobial Treatment of Febrile Neutropenia
DEMİRASLAN H., METAN G., KAYNAR L., ALP MEŞE E., DOĞANAY M.
The 7th EURASIA CONGRESS OF INFECTIOUS DISEASES, 30 September - 03 October 2015, pp.150
2015
2015Are Generic and Original Forms of Piperacillin TazobactamDifferent in Terms of False Galactomannan Test Positivity
DEMİRASLAN H., METAN G., KAYNAR L., ALP MEŞE E., DOĞANAY M.
The 7th EURASIA CONGRESS OF INFECTIOUS DISEASES, 30 September - 03 October 2015, pp.97
2015
2015POST AUTHORIZATION SAFETY OF LENALIDOMIDE DEXAMETHASONE IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA EARLY SAFETY REPORT OF TURKISH PASS STUDY
Tuğlular A. T. F., Pehlivan M., Sarı H. İ., Ayyıldız M. O., Saydam G., Sönmez M., et al.
15th International Myeloma Workshop, Rome, Italy, 23 - 26 September 2015, vol.15, pp.734
2015
2015Akut Lösemi Tedavisinde Alternatif Kök Hücre Kaynakları Güncel Durum
KAYNAR L.
2. Hematolojik Onkoloji Kongresi, Turkey, 9 - 13 September 2015
2015
2015Therapeutic Cancer Vaccine Producing Dendritic Cell from Allogeneic Donor Stem Cells
ÜNAL A., birekul a., ÜNAL M. Ç., KARAKUŞ E., KAYNAR L., ERMİŞ TURAK E., et al.
4th European Congress of Immunology, Viyana, 6 - 09 September 2015, pp.51
2015
2015Diagnostic conflic in MPO deficiency and AR CGD with DHR assay
ÜNAL A., birekul a., ÜNAL M. Ç., KARAKUŞ E., KAYNAR L., ERMİŞ TURAK E., et al.
4th European Congress of Immunology, Viyana, Austria, 6 - 09 September 2015, pp.96
2015
2015A change for the antibacterial treatment policy to decrease carbapenem consumption at a hematopoieteic stem cell transplant center
METAN G., KAYNAR L., YOZGAT N., ELMALI F., KÜRKÇÜOĞLU C. A., ALP MEŞE E., et al.
3rd International Conference on Prevention and Infection Control (ICPIC 2015), Switzerland, 16 - 19 June 2015, vol.4, pp.175
2015
2015The effectiveness of hepa filtered rooms plus fluconazol prophylaxis for preventation of invasive fungal diseases in allogenic stem cell transplant patients
Kürkçüoğlu C. A., Metan G., Kaynar L., Elmalı F., Alp Meşe E., Çetin M.
3rd International Conference on Prevention and Infection Control (ICPIC 2015), Geneve, Switzerland, 16 - 19 June 2015, vol.4, pp.274-275
2015
2015THE ROLE OF AZACITIDINE IN THE TREATMENT OF ELDERLY PATIENTS WITH AML - RESULTS OF A RETROSPECTIVE MULTICENTER STUDY
TOMBAK A., UÇAR M. A., AKDENİZ A., TİFTİK E. N., ŞAHİN D., AKAY O. M., et al.
20th Congress of European-Hematology-Association, 11 June 2015, vol.100, pp.374-375
2015
2015NILOTINIB RESULTS IN IMPROVED RATES OF MOLECULAR RESPONSE IN TURKISH NEWLY DIAGNOSED CML-CP PATIENTS: A 24-MONTH UPDATE
Saydam G., Haznedaroğlu İ. C., Kaynar L., Yavuz A. S., Ali R., Güvenç B., et al.
20thCongress of the European Hematology Association, Vienna, Austria, 11 - 14 June 2015, vol.100, pp.695
2015
2015FACTORS AFFECTING SURVIVAL IN PATIENTS WITH ACUTE LEUKEMIA WHO RECEIVED DONOR LYMPHOCYTE INFUSION IN THE TREATMENT OF FIRST RELAPSE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
KURNAZ F., KAYNAR L., ESER B., ALTUNTAŞ F., ŞIVGIN S., PALA ÖZTÜRK Ç., et al.
20thCongress of the European Hematology Association, Austria, 11 - 14 June 2015, vol.100, pp.606
2015
2015Response of complex undefined hypereosinophilic syndrome to treatment with imatinib: Churg-Strauss syndrome in the differantial diagnosis
YILMAZ İ., KAYNAR L., TUTAR N., PALA Ç., CANÖZ Ö., BÜYÜKOĞLAN H., et al.
European Academy of Allergy and Clinical Immunology Congress, Barcelona, Spain, 6 - 10 June 2015, vol.70, pp.396
2015
2015MDS de Rehberler Eşliğinde Güncel Tedavi Algoritması
KAYNAR L.
I. Karadeniz Hematoloji Sempozyumu, Turkey, 05 June 2015
2015
2015Short term Danazol Prophylaxis of Hereditary Angioedema for Dental Implant Treatment Case Report
GÖNEN Z. B., DOĞRUEL F., KAYNAR L., yılmaz asan c., ÇETİN M.
9. Ağız Çene Yüz Cerrahisi Birliği Derneği(AÇBİD) Uluslararası Kongresi, Antalya, Turkey, 27 - 31 May 2015
2015
20152015 Yılında AML Tanıdan Tedaviye
KAYNAR L.
Uluslararası Özbek-Türk Hematoloji Kongresi, 18 - 20 May 2015
2015
201565 Yaş Üzeri Multipl Myelom Tanılı Hastalarda Otolog Hematopoetik Kök Hücre Naklinin Güvenilirliğinin Değerlendirilmesi
ERMİŞ TURAK E., demir k., KAYNAR L., ŞIVGIN S., ÇETİN M., AKYOL G., et al.
2.Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Turkey, 16 - 19 April 2015
2015
2015T Hücre Seleksiyonu ve Nakil Leylagül Kaynar
KAYNAR L.
II. UluslararasıKatılımlı Deneysel Hematoloji Kongresi, Turkey, 16 - 19 April 2015
2015
2015Bone marrow iron stores BMIS might be used as a predictive marker for survival in patients with iron overload that underwent allogeneic hematopoietic stem cell transplantation alloHSCT
ŞIVGIN S., NAZLIM S., KEKLİK M., YILDIZHAN E., ZARARSIZ G., SOLMAZ M., et al.
41th Annual Meeting of the European Group for Blood and Marrow Transplantation, 22 - 25 March 2015, vol.50, pp.432
2015
2015Elevate pretransplant serum ferritin levels are strongly correlated with poorer survival in patients with lymphoma that underwent autologous hematopoietic stem cell transplantation autoHSCT
ŞIVGIN S., KARAMUSTAFAOĞLU M., ERMİŞ TURAK E., AKYOL G., MANDACI ŞANLI N., KAYNAR L., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation, 22 - 25 March 2015, vol.50, pp.431
2015
2015Collection of Granulocytes for Transfusion to Neutropenic Patients Performance Comparison of Two Apheresis Systems
Kaynar L., Solmaz M., Öztekin M., Baysal S., Şıvgın S., Eser B., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, pp.345
2015
2015The evaluation of the efficacy and safety of original filgrastim Neupogens biosimilar filgrastim Leucostims and Lenograstim Granocytes in CD34 peripheral hematopoietic stem cell mobilisation procedures for alloHSCT donors
ŞIVGIN S., KARAKUŞ E., KEKLİK M., ZARARSIZ G., SOLMAZ M., KAYNAR L., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation, 22 - 25 March 2015, vol.50, pp.367
2015
2015Evaluation of Peripheral Blood Stem Cell Mobilization and Collection in Elderly Patients
Kaynar L., Ünal M. Ç., Birekul A., Yıldızhan E., Şıvgın S., Turak E. E., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation, İstanbul, Turkey, 20 - 25 March 2015, vol.50, pp.562-563
2015
2015Comparison of the Efficiency of High and Low Dose Cyclophosphamide for Stem Cell Mobilization
Ünal A., Ünal M. Ç., Ermiş Turak E., Akyol G., Mandacı Şanlı N., Yıldızhan E., et al.
41st Annual Meeting of the European Society for Blood and Marrow Transplantation, İstanbul, Turkey, 22 - 25 March 2015, vol.50, pp.562-563
2014
2014Fenwal Amicus Fresenius COM TEC and Trima Accel Cell Cihazları ile yapılan Trombosit Aferezinin Karşılaştırılması
keklik m., ESER B., KAYNAR L., solmaz m., yay m., birekul a., et al.
9.ULUSAL AFEREZ KONGRESİ, Turkey, 4 - 07 September 2014
2014
2014Alpha-Beta T- Cell Depleted Haploıdentıcal Hematopoıetıc Stem Cell Transplantatıon As A Treatment Of Hemophagocytıc Syndrome
KEKLİK M., KAYNAR L., AKYOL G., PALA Ç., ESER B., ŞIVGIN S., et al.
40th Annual Meeting of the European Group for Blood and Marrow Transplantation, 30 March - 02 April 2014, vol.49, pp.529
2014
2014TWO CASES OF GUILLAIN BARRE SYNDROME DEVELOPED AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
KARAKÜKCÜ M., KAYNAR L., ÜNAL E., ESER B., ÖZDEMİR M. A., ÇETİN M., et al.
40th Annual Meeting of the European Group for Blood and Marrow Transplantation, 30 March - 02 April 2014, vol.49, pp.486
2014
2014LENFOMADA ERKEN HEMATOPOETİK KÖK HÜCRE NAKLİ
KAYNAR L.
8. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Turkey, 6 - 08 March 2014, pp.28-31
2013
2013ERCİYES TRANSPLANTASYON MERKEZİ ALFA BETA T HÜCRE DEPLESYONLU HAPLOİDENTİK KÖK HÜCRE NAKLİ SONUÇLARI
pala ç., ÇETİN M., KAYNAR L., solmaz m., demir k., ŞIVGIN S., et al.
39.ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 23 - 26 October 2013, pp.44
2013
2013Analysis of lymphoid subgroups and immunoglobulin levels in patients with graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
Kaynar L., Ünal A., Uzer E., Köker M. Y., Yiğit H., Şıvgın S., et al.
39th Annual Meeting of the European Group for Blood and Marrow Transplantation, London, England, 7 - 10 April 2013, pp.532-533
2013
2013A rare but severe complication of G CSF in healthy donor splenic rupture
Akyol G., Pala Öztürk Ç., Yıldırım A., Demir K., Dörtdudak S., Kaynar L., et al.
39th Annual Meeting of the EBMT, London, England, 7 - 10 April 2013, pp.101
2012
2012KEMİK İLİĞİ BİYOPSİSİ İLE NİEMAN PİCK HASTALIĞI TESPİT EDİLEN İLK KARTAGENER SENDROMU OLGUSU
KEKLİK M., ŞIVGIN S., KONTAŞ O., yıldırım a., KARDAŞ F., BALDANE S., et al.
38.Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2012, pp.119-120
2012
2012GRAFT VERSUS HOST HASTALARINDA LENFOSİT VE GRANÜLOSİT ALT GRUPLARININ DAĞILIMI
UYSAL E., YİĞİT H., KÖKER M. Y., KEKLİK M., AKYOL G., KAYNAR L., et al.
38.Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2012, pp.112
2012
2012KOLON KANSERİ TAKİBİNDE GELİŞEN BİR MULTİPLE MYELOMA OLGUSU
KEKLİK M., KARACA H., BERK V., EROL O., ŞIVGIN S., PALA ÖZTÜRK Ç., et al.
38.Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2012
2012
2012ALLOGENİK HEMATOPOETİK KÖK HÜCRE NAKLİ YAPILAN AKUT LENFOBLASTİK LÖSEMİLİ HASTALARDA TÜM VÜCUT IŞINLAMASI+SİKLOFOSFAMİD İLE BUSULFAN+SİKLOFOSFAMİD HAZIRLAMA TEDAVİLERİNİN KARŞILAŞTIRILMASI
EROĞLU C., PALA ÖZTÜRK Ç., KAYNAR L., YARAY K., AKSÖZEN M. T., BANKİR M., et al.
38.Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2012, pp.108-109
2012
2012TOTAL VÜCUT IŞINLAMASI SONRASI GELİŞEN AKUT TRANSVERS MYELİT ATAĞI NADİR BİR OLGU
keklik m., KAYNAR L., yıldırım a., EROĞLU C., ŞIVGIN S., ŞERİFE C., et al.
38. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2012
2012
2012OTOLOG HEMATOPOİETİK KÖK HÜCRE NAKLİ (OTOHKHN) YAPILAN HASTALARDA GRANULOSİTKOLONİ UYARICI FAKTÖR (G-CSF) İLAÇLARININ HÜCRE MOBİLİZASYONUNDAKİ ETKİNLİĞİNİN DEĞERLENDİRİLMESİ: TEK MERKEZ DENEYİMİ
ŞIVGIN S., Karakus E., KEKLİK M., PALA ÖZTÜRK Ç., Solmaz M., ZARARSIZ G., et al.
38.Ulusal Hematoloji Kongresi, Turkey, 31 October - 04 November 2012, pp.117-118
2012
2012ERİŞKİN BİR ATAKSİ TELENJİEKTAZİ HASTASINDA PLEVRAL MAYİDE AKUT LENFOBLASTİK LÖSEMİ TUTULUMUNUN FLOW SİTOMETRİ İLE TESPİTİ
KEKLİK M., KÖKER M. Y., ŞIVGIN S., ÇAMLICA D., PALA ÖZTÜRK Ç., ÇETİN M., et al.
38.Ulusal Hematoloji Kongresi, Turkey, 01 October 2012, pp.92
2012
2012Detection of 1 3 Beta D Glucan in Bronchoalveolar Lavage Fluid for the Diagnosis of Invasive Aspergillosis
ATALAY M. A., METAN G., KOÇ A. N., KAYNAR L., BÜYÜKOĞLAN H., BOZKURT İ., et al.
ICAAC 2012, United States Of America, 1 - 04 September 2012, pp.0-165
2012
2012The regulatory issues concerning a university Cappadoccia centre
Pınarbaşı M., Ünal A., Çetin M., Eser B., Kaynar L., Köker M. Y.
38th Annual Meeting of the European Group for Blood and Marrow Transplantation, Geneve, Switzerland, 1 - 04 April 2012, pp.279
2011
2011DİYABETES MELLİTUS VE SON DÖNEM BÖBREK HASTALIĞININ PERİFERİK KANDAKİ CD34 + HÜCRE SAYISI ÜZERİNE ETKİSİ
PALA ÖZTÜRK Ç., ALTUN İ., KÖKER M. Y., KURNAZ F., ŞIVGIN S., KOÇYİĞİT İ., et al.
37.Ulusal Hematoloji Kongresi, Turkey, 16 - 21 October 2011
2011
2011OTOLOG PERİFERİK KÖK HÜCRE NAKLİ SONRASI ENGRAFTMANI ETKİLEYEN FAKTÖRLER
ŞIVGIN S., DOĞRUEL F., KAYNAR L., KURNAZ F., UZER E., PALA ÖZTÜRK Ç., et al.
37.Ulusal Hematoloji Kongresi, Turkey, 19 - 21 November 2011, pp.83
2011
2011The peformance of galactomannan antigen assay in thediagnosis of invasive pulmonary aspergillosis at differentcutoff values
Metan G., Koç A. N., Atalay M. A., Kaynar L., Öztürk A., Alp Meşe E., et al.
5th Trends in Medical Mycology, Valencia, Spain, 2 - 05 October 2011, pp.80-81
2011
2011What is the role of 1 3 beta D Glucan screening in patients undergoing autologous stem cell transplantation
METAN G., KOÇ A. N., KAYNAR L., ATALAY M. A., ÖZTÜRK A., ESER B., et al.
5th Trends in Medical Mycology, Spain, 1 - 04 October 2011, vol.54, pp.54
2011
2011Diagnosis of Invasive Aspergillosis by Various Microbiology Methods
HÖRMET H. Ö., KOÇ A. N., ATALAY M. A., ESER B., YILDIZ O., KAYNAR L.
The 4th Eurasia Congress of Infectious Diseases, Bosnia And Herzegovina, 1 - 04 June 2011, pp.0-274
2010
2010Increased lung epithelial permeability in healthy donors for allogenic hematopoletic stem cell transplantation detected by Tc 99m DTPA aerosol scintigraphy
KULA M., ESER B., erdoğan z., KAYNAR L., ABDULREZZAK Ü., TUTUŞ A.
World Journal of Nuclear Medicine Congress, South Africa, 1 - 04 October 2010, pp.0-870
2010
2010The Importance Of T315I T317l E255K And Y253H Bcr Abl Gene Mutatıons In The Patıents Of Chronıc Myeloıd Leukemıa Who Treated By Imatınıb
kış c., PEHLİVAN M., PEHLİVAN S., ESER B., SEVER T., yılmaz m., et al.
15th Annual Meeting of the European-Hematology-Association, Spain, 1 - 04 June 2010, vol.95, pp.546
2010
2010Effects of GH replacement therapy on hematopoiesis and immune function a placebo controlled study
ÇAKIR İ., TANRIVERDİ F., ÖZDAMAR KARACA Z. C., KAYNAR L., ELBÜKEN G., ESER B., et al.
European Congress of Endocrinology 2010, Czech Republic, 1 - 04 April 2010, pp.567
2009
2009RESULTS OF DONOR ACQUISITION PROGRAMME CONDUCTEDBY ERCIYES UNVERSITY MEDICAL FACULTY BLOOD BANKING
KURNAZ F., ESER B., YAY M., KAYNAR L., ÜNAL A., ÇETİN M.
XXth Regional Congress of the ISBT, Asia, 14-18 November 2009, Nagoya, Japan, 14 - 18 November 2009
2009
2009Detection and quantification of CMV by two real time PCR tests and pp65 antigenemia in bone marrow transplant recipients
Gökahmetoğlu S., Perçin Renders D., Kaynar L.
12th Annual Meeting of the European Society for Clinical Virology, İstanbul, Turkey, 1 - 04 September 2009, vol.46, pp.6
2007
2007No significant expression of Wt1 gene in multiple myeloma patients at diagnosis Is Wt1 gene expression useful marker for minimal residual disease in multiple myeloma
ÖZKUL Y., ÇAĞLAYAN A. O., KOÇYİĞİT İ., SAATÇİ Ç., AKALIN H., DEMİR A. M., et al.
49th Annual Meeting of the American Society of Hematology, United States Of America, 1 - 04 November 2007
2007
2007Comparison of plateletpheresis on the fenwal amicus and fresenius Com Tec cell separators
ALTUNTAŞ F., KAYNAR L., KOÇYİĞİT İ., HACIOĞLU S., ÖZTÜRK A., KURNAZ F., et al.
60th Annual Meeting of the American-Association-of-Blood-Banks, United States Of America, 1 - 04 October 2007
2007
2007Therapeutic Plasma Exchange in Neurological Diseases single center Experience
ALTUNTAŞ F., KÖSEOĞLu E., KOÇYİĞİT İ., KAYNAR L., KABUKÇU H. S., KURNAZ F., et al.
12th EHA Congress, Austria, 1 - 04 June 2007, pp.523
2007
2007Detection and quantification of cytomegalovirus in bone marrow transplant recipents by real time PCR and PP65 antigenemia
GÖKAHMETOĞLU S., KAYNAR L., ALTUNTAŞ F., YILDIZ O., ESER B., ÜNAL A., et al.
12th Congress of the European-Hematology-Association, Austria, 1 - 04 June 2007, pp.524
2007
2007Autologous peripheral blood stem cell transplatation in patients with relapsed non-Hodgkin lymphoma:cappadocia BMT centre experience
ALTUNTAŞ F., KOÇYİĞİT İ., KAYNAR L., SARI H. İ., HACIOĞLU S., ŞEKERCAN M., et al.
33rd Annual Meeting of the European Group for Blood and Marrow transplantation, France, 1 - 04 April 2007, pp.318
2007
2007Rhabdomyolysis in allogeneic peripheral blood stem cell donor
KAYNAR L., ALTUNTAŞ F., KABUKÇUOĞLU S., KOÇYİĞİT İ., AKYOL L., KARAKÜKCÜ M., et al.
33rd Annual Meeting of the European Group for Blood and Marrow transplantation, France, 1 - 04 April 2007, vol.39, pp.142
2003
2003Tekrarlayan Gebelik Kayıplarında MTHFR C677T Faktör V LEIDEN Faktör II Gen Mutasyon Analizi
TAŞDEMİR Ş., AKALIN H., SAATÇİ Ç., KAYNAR L., ÇETİN M., ÖZKUL Y., et al.
VIII. Ulusal Tıbbi Genetik Kongresi, Turkey, 14 - 17 October 2003
Books
2025
2025Utilization of Clinical Data and Evaluation of Biomarkers in the Investigation of Graft-Versus-Host Disease Outcomes
Çelik S., Kaynar L.
in: Graft-Versus-Host Disease Methods and Protocols, Sluyter Ronald, Editor, Humana Press Inc, New York, pp.71-83, 2025
2025
2025Extracorporeal Photopheresis in Patients with Chronic Graft-Versus-Host Disease
Kaynar L., Mutlu Y. G.
in: Problem Solving in Apheresis Medicine, İlknur Kozanoğlu, Editor, Springer Nature Switzerland Ag, Aarau, pp.191-199, 2025
2024
2024Immunotherapy in Acute Leukemias
Kaynar L., Özgür Y.
in: Immunotherapy in Human Cancers, YILDIZ ORHAN,KAPLAN MUHAMMET ALİ, Editor, Nobel Tıp Kitapevi, İstanbul, pp.61-89, 2024
2020
2020İyileştirme ve Geliştirme Süreci
Güven Z. T., Kaynar L.
in: Hücresel Tedavilerde Kalite Yönetim Sistemi İşletimi - 2020, Boğa Can, Editor, Türkiye Klinikleri Yayınevi, Ankara, pp.50-53, 2020
2019
2019Kronik Graft Versus Host Hastalığı: Kurtarma Tedavileri
Güven Z. T., Kaynar L.
in: Kronik Graft Versus Host Hastalığı, Prof. Dr. Mutlu ARAT,Uzm. Dr. Deniz GÖREN ŞAHİN, Editor, Türkiye Klinikleri, Ankara, pp.24-29, 2019
2015
2015Mediyastinal Lenfomanın Tanı ve Tedavisi
Bilgin M., Kaynar L.
in: MEDİYASTEN HASTALIKLARI VE CERRAHİSİ, Balcı E.A, Editor, Türkiye Solunum Araştırmaları Derneği, Ankara, pp.311-318, 2015
2015
2015Hematoloji-Onkoloji
Kaynar L.
in: Dahiliye Cep Kitabı Özet Bilgiler ve Güncel Notlar, Güven Muhammet,Kaynar Leylagül,Tanrıverdi Fatih., Editor, Güneş Kitabevi, Adana, pp.1-37, 2015
2013
2013Current Status of Hematopoietic Stem Cell Transplantation in Patients with Refractory or Relapse Hodgkin Lymphoma
KAYNAR L., ÇETİN M., ÜNAL A.
in: Innovations in Stem Cell Transplantation, TANER DEMİRER, Editor, Intechopen, pp.289-303, 2013
2012
2012Temel Öğeler 1 - Hastaya Yaklaşım
Kaynar L.
in: Koç Klinik Olgu Çözümleri HEMATOLOJİ, MUSTAFA ÇETİN, Editor, Adana Nobel Kitabevi, Adana, pp.9-17, 2012
2012
2012Olgu 12 - Yorgunluk ve Boğaz Ağrısı olan 40 yaşında bir erkek
Kaynar L.
in: Klinik Olgu Çözümleri Hematoloji, MUSTAFA ÇETİN, Editor, Adana Nobel Kitabevi, Adana, pp.89-95, 2012
Supported Projects
2023 - 2026
2023 - 2026Kazanılmış Midostaurin Dirençli Flt3-Itd Pozitif Akut Miyeloid Lösemide Tüm-Genom Dna Metilom Ve Transkriptomik Değişimlerinin Entegre Analizi: Direncin Aşılmasında Dna Metilasyonu İle Düzenlenen Yeni Moleküler Hedeflerin Belirlenmesi
TUBITAK Project
Adan A.(Executive), Zararsız G., Kaynar L., Budak G.
2020 - 2021
2020 - 2021RATLARDA AKUT VE KRONİK TAMOKSİFEN VERİLMESİ NEDENİYLE OLUŞAN TOKSİK ETKİLER ÜZERİNE PROPOLİSİN KORUYUCU ROLÜNÜNÜN BELİRLENMESİ
Project Supported by Higher Education Institutions
KAYNAR L. (Executive)
2018 - 2020
2018 - 2020KRONİK MYELOİD LÖSEMİDE (KML) TANI VE TAKİBİNDE mikro RNALARIN KULLANILMASININ ARAŞTIRILMASI
Project Supported by Higher Education Institutions
KAYNAR L.
2018 - 2020
2018 - 2020Haploidentik kök hücre nakli yapılan hastalarda aşılara karşı antikor yanıtının değerlendirilmesi
Project Supported by Higher Education Institutions
KAYNAR L.
2017 - 2020
2017 - 2020Ağır Sepsis Ve Septik Şok Hastalarında Mezenkimal Kök Hücre Tedavisinin Sağkalım Üzerine Etkisinin Araştırılması
KAYNAR L.
2017 - 2020
2017 - 2020High Flow Oksijen Tedavisinin Hematolojik Malignensili Akut Hipoksemik Solunum Yetrmezliğindeki Hastalarda Etkinliği
Project Supported by Higher Education Institutions
KAYNAR L.
2017 - 2020
2017 - 2020Nötrofil Kaynaklı Ektozomların Mantar Biyofilmi Üzerine Etkisi
Project Supported by Higher Education Institutions
KAYNAR L.
2016 - 2018
2016 - 2018Kanser Hastalarının Metabolik Durumu Ile F18 Fdg Pet/Bt Temelli Tümör Metabolik Aktivitesinin İlişkisi. ??F18 Fdg Pet/Bt Görüntülemedeki Tümör Hipermetabolizması Tümör Hiperkatabolizmasının Habercisi Mi???
KAYNAR L.
2016 - 2018
2016 - 2018Hematolojik maligniteli hastalarda sitokrom p450 enzimlerindeki genetik polimorfizmler ve serum vorikonazol düzeyi üzerine etkileri
Project Supported by Higher Education Institutions
KAYNAR L.
2016 - 2018
2016 - 2018Multipl Miyelom Hücrelerine Karşı Otolog Kök Hücre ve Mononükleer Hücrelerinden Dendritik Hücre Üretilmesi (Tümör Aşısı Üretimi)
Project Supported by Higher Education Institutions
KAYNAR L.
2015 - 2018
2015 - 2018Kemik İliği Transplantasyonu Yapılan Hastalarda Cytomegalovirus (CMV) Antijeni ve CMV DNA'nın Araştırılması
Project Supported by Higher Education Institutions
KAYNAR L.
2012 - 2018
2012 - 2018Dirençli Nüks Multipl Myeloma Hastalarında Post otorizasyon Güvenlik Çalışması
Project Supported by Other Private Institutions
KAYNAR L.
2014 - 2017
2014 - 2017Alfa Beta T Hücre Azaltılmış Gama Delta T Hücre ve NK Hücre Zenginleştirilmiş Donör Lenfosit İnfüzyonu
TUBITAK Project
KAYNAR L.
2009 - 2014
2009 - 2014AKUT LÖSEMİLİ HASTALARDA 06 METİLGUANİN DNA TARNFERAZ VE MULT HOMOLOG 1 DNA TAMİR GENLERİNİN PROMTOR METİLSAYONUNUN ARAŞTIRILMASI
Project Supported by Higher Education Institutions
KAYNAR L.
2009 - 2012
2009 - 2012RATLARDA SİSPLATİNİN YOLAÇTIĞI HEPATOTOKSİSİTEDE KEKİK VE ÜZÜM ÇEKİRDEĞİ ÖZÜTÜNÜN ETKİLERİNİN ARAŞTIRILMASI
Project Supported by Higher Education Institutions
KAYNAR L.
2007 - 2010
2007 - 2010SİSTEMİK ASPERGİLLUS ENFEKSİYONLARININ FARKLI YÖNTEMLERLE MİKROBİYOLOJİK TANISI
Project Supported by Higher Education Institutions
KAYNAR L.
Memberships / Tasks in Scientific Organizations
2021 - Continues
2021 - ContinuesTürk Aferez Derneği
Member
2018 - Continues
2018 - ContinuesAmerican Society of Hematology
Member
2015 - Continues
2015 - ContinuesInternational Myeloma Working Group (IMWG)
Member
2010 - Continues
2010 - ContinuesThe European Group for Blood and Marrow Transplantation (EBMT)
Member
2005 - Continues
2005 - ContinuesTürk Hematoloji Derneği
Member
2022 - 2023
2022 - 2023TURKISH HEMATOLOGY ASSOCIATION
Board Member
Peer Reviews in Scientific Publications
August 2023
August 2023TURKISH JOURNAL OF HAEMATOLOGY
Journal Indexed in SCI-E
May 2023
May 2023TURKISH JOURNAL OF HAEMATOLOGY
Journal Indexed in SCI-E
April 2023
April 2023TURKISH JOURNAL OF HAEMATOLOGY
Journal Indexed in SCI-E
March 2023
March 2023TURKISH JOURNAL OF HAEMATOLOGY
Journal Indexed in SCI-E
December 2022
December 2022TURKISH JOURNAL OF HAEMATOLOGY
Journal Indexed in SCI-E
August 2022
August 2022TURKISH JOURNAL OF HAEMATOLOGY
Journal Indexed in SCI-E
July 2022
July 2022TURKISH JOURNAL OF HAEMATOLOGY
Journal Indexed in SCI-E
May 2022
May 2022TURKISH JOURNAL OF HAEMATOLOGY
Journal Indexed in SCI-E
Awards
March 2019
March 2019Sözlü bildiri dalında ikincilik ödülü
11.Ulusal Kemik İliği Transplantasyonu Ve Hücresel Tedavileri Kongresi
March 2016
March 20162015 Yılında En Yüksek Impact Faktörlü Dergide Yayın Yapan Öğretim Üyesi
Erciyes Üniversitesi
March 2016
March 2016Gevher Nesibe Araştırma Teşvik Ödülü
Erciyes Üniversitesi
March 2016
March 2016Teşekkür Belgesi
Erciyes Üniversitesi
March 2016
March 20162015 Yılında En Çok Bilimsel Yayın Yapan Öğretim Üyesi
Erciyes Üniversitesi
November 2015
November 201510. Ulusal Aferez Kongresi Poster 1.lik Ödülü
Türk Aferez Derneği
September 2014
September 2014Başarı Ödülü
9.Ulusal Aferez Kongresi
April 2014
April 2014Klinik Hematoloji Ödülü
Deneysel Hematoloji Derneği
March 2014
March 2014BAŞARI TEŞVİK ÖDÜLÜ
Erciyes Üniversitesi
November 2013
November 2013Poster Bildiri İkincilik Ödülünü
23. Ulusal Patoloji Kongresi
October 2013
October 2013Türk Hematoloji Derneği Bildiri Ödülleri
Türk Hematoloji Derneği
October 2013
October 2013Klinik Bilimler Ödülü
Türk Hematoloji Derneği
September 2009
September 2009Prof.Dr. Osman İlhan Hemaferez Ödülü
Hemaferez Derneği
April 2008
April 2008Başarı Teşvik Ödülü
Erciyes Üniversitesi
March 2008
March 2008Geleneksel Gevher Nesibe Araştırma Teşvik Ödülü
Erciyes Üniversitesi
November 2007
November 2007Nilgün Acar Sözlü Sunum Birincilik Ödülü
Iı. Ulusal Kan Merkezleri Ve Transfüzyon Tıbbı Kongresi
October 2007
October 2007THD En Güzel Türkçe Bildiri Ödülü
Türk Hematoloji Derneği
May 2007
May 2007THD Genç Katılımcı Ödülü
Türk Hematoloji Derneği
April 2007
April 2007Başarı Teşvik Ödülü
Erciyes Üniversitesi
February 2006
February 2006THD Genç Katılımcı Ödülü
Türk Hematoloji Derneği
Citations
Total Citations (SCOPUS): 4242
h-index (SCOPUS): 24
Jury Memberships
September-2024
September 2024